Introduction {#S1}
============

Even though cardiovascular therapeutics have advanced rapidly, the global number of patients with atherosclerosis and its complications is on the rise. Changes in life style including an unhealthy diet, low physical activity and obesity contribute to this worldwide epidemic. Despite current management strategies, many individuals still develop first or recurrent cardiovascular events such as myocardial infarction, stroke, heart failure or limb ischemia. Mechanistically, inflammation accounts for some of this residual risk^[@R1]^. Indeed, the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) documented that targeting inflammatory pathways, specifically the cytokine IL-1β, can lower cardiovascular events in selected patients already receiving aggressive management including highly effective statin treatment^[@R2]^.

The cellular protagonists of arterial wall inflammation include leukocytes of several classes, notably macrophages, monocytes and neutrophils. Monocyte and neutrophil blood counts associate with cardiovascular disease progression and death^[@R3]^. Because these cells only live for a day or less, their production rates influence systemic cell abundance and recruitment to cardiovascular organs. Hence, understanding the signals that lead to overproduction of inflammatory leukocytes may provide strategies to reduce inflammatory cardiovascular events^[@R4]^.

Leukocytes derive from hematopoietic stem and progenitor cells (HSPC). HSPC may increase proliferation and thus leukocyte production in response to cytokines, growth factors and danger signals. Recent research has unraveled mechanisms that influence hematopoiesis in cardiovascular disease by illuminating pathways through which hyperlipidemia^[@R5]^, psychosocial stress^[@R6]^, insufficient sleep^[@R7]^ and obesity^[@R8]^ increase HSPC proliferation and the marrow's myeloid cell output. These well-known risk factors either act directly on HSPC or via the hematopoietic niche, an ensemble of stromal bone marrow cells that protects HSPC and instructs their proliferation, migration and lineage bias^[@R9]^.

Sedentary life style is a risk factor for myocardial infarction, while physical activity appears to protect against cardiovascular disease^[@R10]^. One observational study followed 55,137 adults over 15 years and reported that persistent running associates with a 50% lower cardiovascular mortality^[@R11]^. Most available data^[@R10]^ indicate that this relationship rests on metabolic and anti-hypertensive effects which counter aging processes; however, the mechanisms by which physical activity could mitigate cardiovascular inflammation remain uncertain. Exercise has clear effects on the immune^[@R12]^ and cardiovascular system^[@R13]--[@R15]^. Whether and how regular physical activity affects the hematopoietic system is incompletely understood. We therefore studied the hematopoietic system, which is well-characterized in mice, as a function of regular voluntary physical activity.

Results {#S2}
=======

Voluntary running promotes HSPC quiescence {#S3}
------------------------------------------

To explore if regular physical activity modulates hematopoiesis and the systemic supply of leukocytes, we provided mice with running wheels, which they used avidly ([Extended Data Fig. 1a](#F7){ref-type="fig"},[b](#F7){ref-type="fig"}), for six weeks ([Fig. 1a](#F1){ref-type="fig"}). Habitual voluntary running, which increases activity 20-fold compared to sedentary mice^[@R16]^, reduced body weight, augmented food consumption ([Extended Data Fig. 1c](#F7){ref-type="fig"}--[e](#F7){ref-type="fig"}) and did not change skeletal muscle leukocyte recruitment ([Extended Data Fig. 1f](#F7){ref-type="fig"},[g](#F7){ref-type="fig"}) or bone architecture ([Extended Data Fig. 1h](#F7){ref-type="fig"}--[k](#F7){ref-type="fig"}). Voluntary running promoted HSPC quiescence: Lin- Sca-1+ c-Kit+ (LSK) proliferated 34% less, as assessed by BrdU incorporation ([Fig. 1b](#F1){ref-type="fig"},[c](#F1){ref-type="fig"}). The reduction in proliferation occurred at the stage of multipotent progenitors (MPP, a subset of LSK) ([Fig. 1c](#F1){ref-type="fig"}) and in all leukocyte progenitors, regardless of myeloid or lymphoid lineage ([Extended Data Fig. 2a](#F8){ref-type="fig"}--[d](#F8){ref-type="fig"}). BrdU washout assays confirmed that all progenitors downstream of CD48^−^CD150^+^ long-term HSC and CD48^−^CD150^−^ short-term HSC proliferated less in running mice ([Extended Data Fig. 2e](#F8){ref-type="fig"},[f](#F8){ref-type="fig"}). Progenitors formed fewer myeloid and lymphoid colonies, while the erythroid lineage was less affected ([Fig. 1d](#F1){ref-type="fig"}, [Extended Data Fig. 2g](#F8){ref-type="fig"},[h](#F8){ref-type="fig"}). Running mice mobilized fewer HSPC to the circulation from the marrow ([Fig. 1e](#F1){ref-type="fig"}), which, viewed together with decreased differentiation into mature leukocytes ([Extended Data Fig. 2i](#F8){ref-type="fig"}), explains why HSPC numbers in the marrow were preserved ([Extended Data Fig. 2j](#F8){ref-type="fig"}).

The hematopoietic effects of exercise reduced circulating leukocyte numbers ([Fig. 1f](#F1){ref-type="fig"}--[j](#F1){ref-type="fig"}). Differences between running and sedentary cohorts peaked at Zeitgeber time 7 in the blood ([Fig. 1f](#F1){ref-type="fig"}), indicating decreased leukocyte release when mice rest, and at Zeitgeber time 13 in the bone marrow ([Fig. 1g](#F1){ref-type="fig"}), indicating reduced nocturnal leukocyte production. Physical activity lowered all leukocyte subsets ([Fig.1 i](#F1){ref-type="fig"},[j](#F1){ref-type="fig"}, [Extended Data Fig. 2i](#F8){ref-type="fig"}). We further observed a decrease in platelets but not in red blood cells, hemoglobin or hematocrit ([Extended Data Fig. 2k](#F8){ref-type="fig"}). We found that voluntary running did not change the marrow's autonomic nervous system activity, as mass spectrometry documented unchanged bone marrow norepinephrine and acetylcholine concentration ([Extended Data Fig. 3a](#F9){ref-type="fig"}). Nor did we observe any differences in local leukocyte acetylcholine production ([Extended Data Fig. 3b](#F9){ref-type="fig"}), after muscarinic cholinergic receptor inhibition ([Extended Data Fig. 3c](#F9){ref-type="fig"}) or in levels of the stress hormone corticosterone ([Extended Data Fig. 3d](#F9){ref-type="fig"}). Given the habitual voluntary running wheel use by mice in our study, higher blood leukocyte levels in sedentary mice indicate that lack of physical activity in humans partially confers cardiovascular risk via increased systemic leukocyte supply.

Exercise increases CXCL12 in the hematopoietic niche via lowering leptin {#S4}
------------------------------------------------------------------------

To investigate how physical activity alters leukocyte supply, we examined the hematopoietic niche that instructs HSPC activity^[@R9],[@R21]^. The bone marrow of exercising mice displayed increased expression of important HSPC quiescence and retention genes, specifically *Cxcl12, Vcam1, Scf* and *Angpt1,* as well as increased CXCL12 protein levels ([Fig. 2a](#F2){ref-type="fig"}--[c](#F2){ref-type="fig"}). It is well understood that these signals instruct hematopoiesis in many settings^[@R9],[@R21]^; however, their modulation by physical activity was previously unknown. We next assessed gene expression among key stromal cells defining the hematopoietic niche. In running mice, only leptin receptor^+^ (LepR-YFP^+^) stromal cells express more *Cxcl12*, *Vcam1*, *Scf* and *Angpt1* ([Fig. 2d](#F2){ref-type="fig"}). Expression of these genes did not change in other hematopoietic niche cells, including Nestin-GFP^+^ mesenchymal, OCN-GFP^+^ osteoblastic, endothelial cells and macrophages ([Extended Data Fig. 3e](#F9){ref-type="fig"}--[h](#F9){ref-type="fig"}). Overall niche cell numbers did not differ between sedentary and exercising mice ([Extended Data Fig. 3i](#F9){ref-type="fig"}). Expression of other niche factors (*Csf1-3, Ccl2, Il7, Tgfb1* and *Pfa4*) and adipocyte-(*Lpl, Fabp4*) and osteolineage-specific (*Osx, Ocn, Runx2*) genes was unaltered ([Extended Data Fig. 3j](#F9){ref-type="fig"},[k](#F9){ref-type="fig"}).

Hematopoietic niche profiling indicated that leptin receptor^+^ stromal cells relay exercise effects, hence we investigated potential pathways related to the hormone leptin, which decreases appetite and is a pro-inflammatory adipokine^[@R22]^. Exercise reduced body fat ([Extended Data Fig. 4a](#F10){ref-type="fig"}), adipose tissue expression of inflammatory cytokines ([Extended Data Fig. 4b](#F10){ref-type="fig"}) as well as adipose tissue macrophage numbers and their proliferation ([Extended Data Fig. 4c](#F10){ref-type="fig"}--[e](#F10){ref-type="fig"}). In running mice, visceral adipose tissue produced less leptin ([Fig. 2e](#F2){ref-type="fig"}), leading to decreased levels of the hormone in blood and bone marrow ([Fig. 2f](#F2){ref-type="fig"},[g](#F2){ref-type="fig"}). While exercise led to smaller marrow adipocytes in the red marrow of the proximal tibia, adipocyte differentiation and numbers did not change ([Extended Data Fig. 4f](#F10){ref-type="fig"}--[h](#F10){ref-type="fig"}) and the overall marrow fat content remained constant ([Extended Data Fig. 4i](#F10){ref-type="fig"},[j](#F10){ref-type="fig"}). Leptin expression in the marrow was low and unaffected by exercise ([Extended Data Fig. 4k](#F10){ref-type="fig"}) and the marrow leptin concentration did not correlate with tibial adipocyte size ([Extended Data Fig. 4l](#F10){ref-type="fig"}), supporting a prominent role of visceral fat as the source of leptin.

Viewing these data together with previous reports that leptin deficiency impairs hematopoiesis^[@R23]^, that leptin levels correlate with leukocytes in adolescent Japanese males^[@R24]^ and that exercise reduces leptin levels^[@R25]^, we reasoned that exercise-induced changes in hematopoiesis may result from reduced adipose tissue-derived leptin. To test this hypothesis, we elevated leptin to sedentary levels during exercise using mini-pump supplementation ([Fig. 2h](#F2){ref-type="fig"}; [Extended Data Fig. 5a](#F11){ref-type="fig"}). This intervention restored circulating leukocytes ([Fig. 2h](#F2){ref-type="fig"}) and LSK proliferation ([Extended Data Fig. 5b](#F11){ref-type="fig"}), while bone marrow *Cxcl12*, *Vcam1* and *Angpt1* expression declined to the levels seen in sedentary mice ([Extended Data Fig. 5c](#F11){ref-type="fig"}). The chosen leptin concentration did not affect the running distance ([Extended Data Fig. 5d](#F11){ref-type="fig"}). In sedentary mice, leptin neutralizing antibody treatment reduced hematopoiesis while leptin injections had the opposite effect ([Extended Data Fig. 5e](#F11){ref-type="fig"}).

Prior reports state that short-term ablation of leptin receptor-positive stromal cells and deletion of niche factors in leptin receptor-positive cells depletes HSC^[@R26],[@R27]^. However, constitutive leptin receptor deficiency in stromal cells does not affect hematopoiesis but rather remodels the bone marrow niche^[@R28]^. Leptin may also act directly on HSPC^[@R23]^. Therefore, we aimed to clarify how leptin affects hematopoiesis: via direct action on HSPC or indirectly via leptin receptor^+^ stromal cells in the hematopoietic niche. Using LepR-tdTomato reporter mice, we profiled hematopoietic and stromal bone marrow cells by flow cytometry. While there was a distinct tdTomato+ stromal cell population expressing the leptin receptor, leukocytes and HSPC were tdTomato-negative ([Extended Data Fig. 6a](#F12){ref-type="fig"}--[c](#F12){ref-type="fig"}). Adding increasing concentrations of leptin to a colony forming unit assay did not change the number of colonies ([Extended Data Fig. 6d](#F12){ref-type="fig"}). Further, exercise effects on hematopoiesis were preserved in wild type mice that had received lethal irradiation followed by bone marrow transplantation from db/db mice which lack the leptin receptor ([Extended Data Fig. 6e](#F12){ref-type="fig"}--[i](#F12){ref-type="fig"}). Tamoxifen-induced, stromal cell-specific deletion of the leptin receptor in adult *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice, which show no differences in systemic leptin levels ([Extended Data Fig. 6j](#F12){ref-type="fig"}), increased expression of HSPC maintenance niche factors in the bone marrow, reduced LSK proliferation and decreased circulating leukocytes ([Fig. 2i](#F2){ref-type="fig"}--[l](#F2){ref-type="fig"}), an exact phenocopy of running mice. Developmental compensation likely accounts for the differences between our observations two weeks after tamoxifen-induced leptin receptor deletion in adult mice and previously reported data^[@R28]^ obtained in mice with constitutive leptin receptor knock out in stromal cells. In line with this notion, two weeks after tamoxifen injections, we do not observe effects on osteogenesis ([Extended Data Fig. 6k](#F12){ref-type="fig"},[l](#F12){ref-type="fig"}) previously described in mice with constitutive leptin receptor deficiency^[@R28]^. We conclude that reduced leptin signaling leads to increased production of quiescence-promoting niche factors by leptin receptor-positive stromal cells, which in turn lowers HSPC proliferation and leukocyte output.

Voluntary running reduces LSK chromatin accessibility {#S5}
-----------------------------------------------------

To explore how long exercise effects persist, we provided mice with running wheels for six weeks followed by three weeks of running wheel withdrawal (post-exercise-sedentary group, [Fig. 3a](#F3){ref-type="fig"}). Although running-induced leptin reduction and effects on hematopoietic niche factors waned in this cohort ([Extended Data Fig. 7a](#F13){ref-type="fig"}--[c](#F13){ref-type="fig"}), circulating leukocytes and LSK proliferation remained lower than in sedentary mice ([Fig. 3b](#F3){ref-type="fig"}). By six weeks after cessation of running, the exercise effects on LSK proliferation and blood leukocytes vanished completely ([Extended Data Fig. 7d](#F13){ref-type="fig"},[e](#F13){ref-type="fig"}). These observations suggest that adaptations to exercise convey short-term memory effects in hematopoietic cells. To test this hypothesis, we transplanted LSK obtained from CD45.1^STEM^ (reference^[@R29]^) sedentary and CD45.2 exercising mice in a 1:1 ratio into irradiated sedentary UBC-GFP recipients ([Fig. 3c](#F3){ref-type="fig"}). In agreement with the quiescent LSK phenotype in exercising mice, LSK obtained from sedentary donors contributed 1.8-fold more circulating leukocytes ([Fig. 3d](#F3){ref-type="fig"},[e](#F3){ref-type="fig"}) even though LSK engrafted equally ([Fig. 3f](#F3){ref-type="fig"}). LSK derived from running mice proliferated less after transplantation into sedentary recipients, while LT-HSC numbers were similar ([Fig. 3g](#F3){ref-type="fig"}). Competitive LSK transplantation from sedentary versus post-exercise-sedentary donors yielded equal contribution to blood leukocytes, while competition of LSK from exercising versus post-exercise sedentary mice led to a transitional result ([Extended Data Fig. 7f](#F13){ref-type="fig"}).

These data indicate that exercise effects on HSPC last several weeks longer than those on leptin, leptin-receptor-positive stromal cells and the niche factors produced by them. To test whether exercise memory in hematopoietic cells arises from epigenetic alterations, we performed an assay for transposase-accessible chromatin using sequencing (ATAC-seq) on LSK sorted from sedentary, exercising and post-exercise-sedentary cohorts ([Fig. 3h](#F3){ref-type="fig"}). Most ATAC-seq peaks in LSK mapped to promoter regions ([Fig. 3i](#F3){ref-type="fig"}) in close proximity to transcriptional start sites (TSS, [Fig. 3j](#F3){ref-type="fig"}). Overall chromatin accessibility at promoters was reduced in LSK from exercising mice compared to sedentary mice ([Fig. 3j](#F3){ref-type="fig"}), while the background signal was comparable in all groups excluding experimental bias ([Extended Data Fig. 8a](#F14){ref-type="fig"}). Reduced chromatin accessibility of LSK was maintained in mice that had stopped exercising ([Fig. 3j](#F3){ref-type="fig"}). Comparing LSK from different activity groups revealed that chromatin proximal to 2480 genes was significantly less accessible following exercise, while only 12 genes were more accessible (FDR\<0.01; [Fig. 3k](#F3){ref-type="fig"}--[m](#F3){ref-type="fig"}; [Extended Data Fig. 8b](#F14){ref-type="fig"}; [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). The reduced chromatin accessibility in LSK persisted in post-exercise sedentary mice ([Fig. 3k](#F3){ref-type="fig"}--[m](#F3){ref-type="fig"}; [Extended Data Fig. 8c](#F14){ref-type="fig"}--[e](#F14){ref-type="fig"}). Pathway enrichment analysis revealed that the genes with significantly reduced chromatin accessibility in LSK following exercise are involved in transcription and cell cycle regulation ([Fig. 3n](#F3){ref-type="fig"}). Similar to exercising mice, LSK from post-exercise-sedentary mice showed reduced accessibility among genes involved in cell cycle, nucleosome organization and mRNA processing ([Extended Data Fig. 8d](#F14){ref-type="fig"}). Several genes involved in proliferation, myelopoiesis and B lymphopoiesis were significantly less accessible in LSK of exercising and post-exercise-sedentary mice ([Fig. 3k](#F3){ref-type="fig"}--[n](#F3){ref-type="fig"}; [Extended Data Fig. 8c](#F14){ref-type="fig"}--[e](#F14){ref-type="fig"}; [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). Therefore, voluntary exercise induces alterations in the LSK epigenome that suppress accessibility and expression of genes involved in HSPC proliferation and lineage fate decisions. Not only are these changes maintained three weeks following running wheel withdrawal, they also functionally translate to the observed exercise effects on hematopoiesis and circulating leukocytes.

We complemented ATAC-seq with RNA-seq in LSK sorted from the marrow of sedentary, exercising and post-exercise-sedentary cohorts (see [Supplementary Table 2](#SD1){ref-type="supplementary-material"} for differentially expressed genes). A direct comparison of individual genes that scored in ATAC-seq as being less accessible after exercise with genes whose transcripts declined did not reach formal significance. This result is not unexpected, as a lack of direct overlap between chromatin accessibility and differential expression on the single gene level has been reported previously^[@R30]^. Moreover, it has been shown that establishment of chromatin architecture in mouse and human HSPC reveal the differential potential of progeny prior to the execution of an RNA transcriptional program^[@R31]--[@R33]^. Nonetheless, similar biological themes did emerge from our ATAC- and RNA-seq data analysis, reflecting heightened hematopoiesis in sedentary mice, which was reduced by voluntary exercise and maintained for a period following exercise withdrawal. Gene set enrichment analysis (GSEA) revealed a significant downregulation of the \"Reactome Cell Cycle\" gene set in LSK of exercising mice. Specifically, "Reactome Cell Cycle" was the second most significantly downregulated gene set (out of 410 Reactome gene sets) in exercising mice (FDR=0.004), \#49 out of 410 in post-exercise-sedentary mice (FDR=0.01, likely reflecting their gradual return to sedentary state), and when both of these groups were jointly compared to sedentary mice (\#13 out of 410, FDR=0) ([Fig. 3o](#F3){ref-type="fig"}). Gene ontology biological process categories featuring immune activation including phagocytosis, complement activation, and several immune responses ([Fig. 3p](#F3){ref-type="fig"}) enriched in downregulated genes of exercising and post-exercising-sedentary mice. Reactome gene sets enriched in downregulated genes of exercising mice included G-protein coupled receptor signaling ([Fig. 3q](#F3){ref-type="fig"}). These receptors are critically involved in regulating HSPC retention, migration, proliferation and lineage bias^[@R34]^. Finally, GSEA documented a metabolic switch from glycolysis in LSK from exercising mice towards oxidative phosphorylation in sedentary mice ([Fig. 3r](#F3){ref-type="fig"}), which typically occurs if HSPC transition from quiescence towards proliferation^[@R35]^.

Exercise augments emergency hematopoiesis and improves survival in sepsis {#S6}
-------------------------------------------------------------------------

Given our finding that exercise reduces circulating leukocytes and that clearance of infections relies on swift leukocyte supply, we wondered if this relative leukopenia exposes the host to a greater risk from infections, as described after acute exercise^[@R36],[@R37]^. To explore if physical activity alters emergency hematopoiesis, we challenged mice with intraperitoneal injections of lipopolysaccharide (LPS), a bacterial cell wall component that induces the inflammatory responses in sepsis. Runners' hematopoietic progenitors responded vigorously with a 1.4-fold increase of colony-forming units compared to sedentary littermates ([Fig. 4a](#F4){ref-type="fig"},[b](#F4){ref-type="fig"}). Higher HSPC numbers ([Fig. 4c](#F4){ref-type="fig"}) gave rise to more neutrophils, monocytes, B cells and T cells in the blood and peritoneal cavity ([Fig. 4d](#F4){ref-type="fig"},[e](#F4){ref-type="fig"}). When exposed to sepsis after cecal ligation and puncture, exercising mice had a significantly lower mortality than sedentary mice ([Fig. 4f](#F4){ref-type="fig"}--[h](#F4){ref-type="fig"}). These findings, together with the earlier observation that exercise increases macrophage inflammatory cytokine production^[@R38]^, argue against a compromised immune response in individuals that exercise regularly, and indicate that exercise does not inhibit emergency hematopoiesis in the setting of infection.

Leptin receptor deletion dampens infarct inflammation {#S7}
-----------------------------------------------------

In cardiovascular disease, emergency hematopoiesis is triggered by organ ischemia; we therefore studied how exercise influences the hematopoietic response after acute myocardial infarction (MI). Leptin increases in the blood of patients^[@R39],[@R40]^ and in the blood and tibia of mice with MI ([Fig. 5a](#F5){ref-type="fig"}). On day 6 after MI, leptin levels were comparable in exercising and sedentary mice ([Extended Data Fig. 9a](#F15){ref-type="fig"},[b](#F15){ref-type="fig"}). Leukocyte numbers in the acute infarct did not change with exercise and rose further with leptin minipump supplementation ([Extended Data Fig. 9c](#F15){ref-type="fig"},[d](#F15){ref-type="fig"}). Functional post-MI recovery was similar between sedentary and exercising mice ([Extended Data Fig. 9e](#F15){ref-type="fig"}). Disrupting post-MI leptin sensing by stromal bone marrow niche cells in *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice augmented production of hematopoietic niche factors and reduced LSK proliferation ([Fig. 5b](#F5){ref-type="fig"}--[d](#F5){ref-type="fig"}). Marrow harvested from *Prx1*-creER^T2^*:Lepr*^fl/fl^ mice after MI gave rise to fewer colonies ([Fig. 5e](#F5){ref-type="fig"}). As a result of blunted post-MI emergency hematopoiesis, systemic and cardiac leukocyte numbers declined in *Prx1*-creER^T2^*:Lepr*^fl/fl^ mice ([Fig. 5f](#F5){ref-type="fig"},[g](#F5){ref-type="fig"}). Such dampening of emergency hematopoiesis was replicated by leptin-neutralizing antibody treatment 30 minutes after MI, which decreased bone marrow colony forming units, GMP proliferation and monocytes in the blood and infarct ([Extended Data Fig. 9f](#F15){ref-type="fig"}--[j](#F15){ref-type="fig"}). In accord with clinical data correlating post-MI leukocyte levels with heart failure severity^[@R41]^ and post-MI outcomes^[@R42]^, reduced leukocytosis in *Prx1*-creER^T2^*:Lepr*^fl/fl^ mice improved recovery and reduced heart failure post-MI, indicated by lower ventricular volumes and preserved ejection fraction measured by magnetic resonance imaging 3 weeks after MI ([Fig. 5h](#F5){ref-type="fig"}--[j](#F5){ref-type="fig"}). Histological analyses of the infarct border zone 7 days after MI indicated that this improved recovery is due to faster resolution of inflammation and lessened fibrosis ([Extended Data Fig. 9k](#F15){ref-type="fig"},[l](#F15){ref-type="fig"}). Taken together, these data indicate that exercise does not inhibit emergency hematopoiesis after acute MI; however, disruption of leptin signaling by deleting its receptor exerts beneficial effects on post-MI recovery via dampening leukocyte supply to the heart.

Sedentary lifestyle accelerates leukocyte supply in mice and patients with atherosclerosis {#S8}
------------------------------------------------------------------------------------------

Systemic leukocyte availability correlates with atherosclerosis severity in mice^[@R43]^ and humans^[@R3]^, exercise prevents atherosclerotic plaque initiation^[@R13]^ and progression^[@R14],[@R15]^ and a sedentary life style associates strongly with cardiovascular risk. Since we found that physical activity in healthy mice influences leukocyte supply, we argued that exercise, at least to some extent, affects atherosclerosis via dampening of leukocyte production and plaque inflammation. We thus gave ApoE^−/−^ mice with established atherosclerosis access to running wheels, which significantly reduced blood and tibial leptin concentration, inhibited progression of hyperlipidemia-associated leukocytosis, lowered immune cell accumulation in the aorta and decreased the size of atherosclerotic plaques in the aortic root ([Fig. 6a](#F6){ref-type="fig"}--[j](#F6){ref-type="fig"}). To examine the role of leptin in atherosclerosis mechanistically, we induced atherosclerosis in *Prx1*-creER^T2^*:Lepr*^fl/fl^ mice using a combination of atherogenic diet and PCSK9 AAV. Compared to littermate *Lepr*^fl/fl^ controls, deletion of the leptin receptor resulted in reduced atherosclerotic plaque size and macrophage content ([Extended Data Fig. 10a](#F16){ref-type="fig"}--[d](#F16){ref-type="fig"}). Mechanistically, this was tied to lower HSC and GMP proliferation and reduced circulating neutrophils and monocytes ([Extended Data Fig. 10e](#F16){ref-type="fig"}--[h](#F16){ref-type="fig"}). Of note, in contrast to mice without atherosclerosis, we here observed exercise effects even on the level of CD48^−^CD150^+^ long-term HSC, possibly because of combined effects of hyperlipidemia, atherosclerosis and sedentary behavior.

These observations raised the question whether exercise also has beneficial effects on hematopoiesis in patients with existing CVD. We assessed the association between self-reported exercise and plasma leptin levels or the total white blood cell count measured at baseline among 4,892 participants in the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) that enrolled individuals who had sustained an MI^[@R2]^. Plasma levels of leptin and the total leukocyte count were lower among CANTOS participants who exercised 4 or more times per week as compared to those with lower exercise levels (P\<0.001 in both univariate and multivariate analyses, [Fig. 6k](#F6){ref-type="fig"}). CVD patients enrolled in the Athero-Express Study^[@R44]^ showed a similar relationship between blood leukocyte numbers, leptin and physical activity even when corrected for age, sex, BMI, smoking, diabetes, hypercholesterolemia and statin use ([Fig. 6l](#F6){ref-type="fig"}, [Extended Data Fig. 10i](#F16){ref-type="fig"}, [Supplementary Table 3](#SD1){ref-type="supplementary-material"}--[5](#SD1){ref-type="supplementary-material"}). The association observed in two independent clinical cohorts, viewed together with the data obtained in mice, indicates that physical activity exerts beneficial effects on leptin and leukocytosis in CVD patients.

Discussion {#S9}
==========

Our preclinical data show that voluntary physical activity protects against CVD via reduced chronic hematopoietic output of inflammatory leukocytes, due to diminished leptin signaling to the stromal hematopoietic bone marrow niche ([Fig. 6m](#F6){ref-type="fig"}). Leptin levels increase when energy is abundant^[@R45]^. The hormone's role in regulating energetically costly hematopoiesis may have evolved to produce blood cells at times of resource sufficiency. However, contemporary sedentary behavior, which increases leptin and consequently hematopoiesis, may have rendered this adaption a risk factor for CVD, and perhaps also for other diseases with inflammatory components.

The leukocyte reduction in voluntary-running mice contrasts sharply with increased hematopoiesis, increased cell mobilization from the marrow and leukocytosis reported for forced endurance training^[@R17],[@R19],[@R20]^. This difference may arise from exercise intensity and the stressful electric shocks used to enforce running^[@R17],[@R20]^. Such stress may activate sympathetic signaling and consequently accelerate HSPC proliferation^[@R6]^.

The associations between sedentary life style, leptin and leukocyte levels in the two independent, large cardiovascular patient cohorts we describe here extend previous human data^[@R24],[@R25],[@R46],[@R47]^ and support the clinical relevance of the pathways we target in sedentary mice. In accord with these clinical data, leukocytosis and plaque size increase in sedentary mice with established atherosclerosis. The observed health benefits of physical activity are likely multifactorial and not limited to leptin-dependent regulation of hematopoiesis. Since exercise improves sepsis survival in mice, molecular alterations produced by voluntary running may inform anti-inflammatory drug discovery by identification of targets that do not compromise host defenses.

The insight that regular voluntary physical activity reduces hematopoiesis illuminates a new pathway by which sedentary lifestyle contributes to cardiovascular risk via oversupply of disease-promoting leukocytes. These data also support the notion that physical activity lessens existing chronic inflammation. Implementing guidelines^[@R48]^ that recommend 150 min of exercise per week and the development of drugs that mimic the effects of voluntary exercise on hematopoiesis offer modalities to mitigate inflammation in cardiovascular disease.

Methods {#S10}
=======

CANTOS. {#S11}
-------

We assessed for evidence of association between self-reported exercise and plasma levels of leptin or the total white blood cell count measured at baseline among 4,892 participants in the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) who had a prior history of myocardial infarction and who were receiving aggressive secondary preventive care including high-intensity statin therapy^[@R2]^. Leptin levels (R&D Systems) and the total leucocyte count were evaluated in a central laboratory while exercise levels were categorized as rarely, 1 to 3 sessions per week, 4 to 6 sessions per week, or daily. Tests for significance across exercise categories were evaluated in univariate analyses using the Kruskal-Wallis test, while multivariate regression analyses were used to address for effects after adjustment for age, gender, body mass index, education level, history of heart failure and hemoglobin A1c. The study protocol was approved at participating centers by the responsible institutional review board or ethics committee, as applicable in the 39 countries involved.

Athero-Express. {#S12}
---------------

All patients included in the present analysis were enrolled in the Athero-Express Biobank Study (AE)^[@R44],[@R49]^. The AE is an ongoing, longitudinal biobank that combines blood and atherosclerotic plaque specimens with baseline characteristics and three-year follow-up data from patients undergoing surgical revascularization to treat carotid or ilio-femoral stenosis. Patient characteristics were obtained through standardized preoperative questionnaires and preoperative admission charts. All patients underwent surgery between 2005 and 2016 in the University Medical Center Utrecht (UMCU). Indication for surgery was based on international guidelines for carotid and peripheral surgical revascularization^[@R50]^. This study was conducted in accordance with the Declaration of Helsinki, and all patients provided written informed consent. Patients were first stratified into two groups based on the information provided in response to the question about whether they performed any exercise. Patients who did not perform any exercise served as the reference group. To study dose-dependent effects of exercise, patients were further stratified into tertiles based on the number of hours exercised per week. A flowchart of the study design is provided in [Extended Data Fig. 10i](#F16){ref-type="fig"}. Hematological measurements were obtained from the Utrecht Patient Orientated Database (UPOD)^[@R51]^. Hematological parameters were measured using the Abbott CELL-DYN Sapphire (Abbott Diagnostics)^[@R52],[@R53]^.

Leptin measurements were performed in 44 patients per exercise group on blood drawn before surgeries. A custom-built Leptin Human Magnetic Luminex Assay (Standard Curve 493 -- 119830 pg/mL, sensitivity 10.2 pg/mL, R&D Systems) was used in combination with the Bio-Plex Multiplex system (Bio-Rad). Analyses were performed according to the manufacturers' protocol. Patients with Leptin levels that were below the detection limit of the assay (n=2) were excluded.

Patients were categorized in four exercise groups, based on hours of exercise per week. Differences in binary characteristics between the four groups were analyzed with Pearson's Chi square test. Differences in continuous variables among the four groups were tested using one-way analysis of variance. White blood cell counts were compared among groups using one-way analysis of variance and multivariate linear regression models. Possible confounders were selected based on differences in baseline characteristics among the four exercise groups, and association with the hematologic parameter of interest (p value \<0.10). SPSS 21.0 (SPSS Inc) was used for all statistical analyses. The study protocol was approved by the medical ethics committee of the UMCU.

Mice. {#S13}
-----

Seven- to eight-week-old male C57BL/6J mice were used for exercise studies if not indicated otherwise. UBC-GFP (C57BL/6-Tg(UBC-GFP)30Scha/J, 004353), CD45.1 (B6.SJL-Ptprc^a^Pepc^b^/BoyJ, 002014) and ApoE^−/−^ mice (B6.129P2-Apoe^tm1Unc^/J, 002052) were purchased from The Jackson Laboratory. Stromal cell reporter mice (Nestin-GFP^[@R54],[@R55]^, LeptinRcre-R26-YFP or R26-Tdtomato^[@R27],[@R56]^ and OCN-GFP^topaz\ [@R57]^, CD45.1^STEM^ mice^[@R29]^ and Prx1-creER^T2^-(B6.Cg-Tg(Prrx1-cre/ERT2,-EGFP)1Smkm/J; JAX: 029211) crossed with Lepr^fl^ (B6.129P2-Lepr^tm1Rck^/J; JAX: 008327) were bred in-house. Genotyping for each strain was performed as described on the Jackson Laboratory website. For the Nestin-GFP and OCN-GFP^topaz^ mice, we used genotyping primers that target specifically the GFP construct (Forward primer: 5'-CTGGTCGAGCTGGACGGCGACGTAAC-3'; Reverse primer: 5'-ATTGATCGCGCTTCTCGTTGGGG-3'). For inducible deletion of the leptin receptor, we intraperitoneally administered 75 mg/kg tamoxifen (T5648, Sigma-Aldrich) dissolved in corn oil (C8267, Sigma-Aldrich), according to the Jackson laboratory protocol, every second day for 5 days (3 injections total). In all experiments, littermate control mice were subjected to the same tamoxifen regimen.

For atherosclerosis experiments in Lepr^fl/fl^ and Prx1-creER^T2^:Lepr^fl/fl^ strains, mice received a single IV injection of AAV-PCSK9 (10^12^ genome copies in 200 μL of PBS) 2 weeks after the initial tamoxifen injections as described previously^[@R58]^. pAAV/D377Y-mPCSK9 was a gift from Jacob Bentzon (Addgene plasmid \#58376 ; <http://n2t.net/addgene:58376> ; RRID:Addgene_58376). Following AAV-PCSK9 injection, mice were placed on a high fat diet (D12108C, Research Diets Inc.) and underwent single injections of 75 mg/kg tamoxifen at 4 and 8 weeks after start of high fat diet.

All mice were housed in separate cages in a pathogen-free environment of the Massachusetts General Hospital animal facility and maintained on a 12-hour light/dark cycle with a room temperature of 22 ± 1°C. Mice received standard mouse chow and water ad libitum, except for ApoE^−/−^ mice, which consumed a Western-type diet (TD.88137, Teklad Custom Diets, Envigo), and mice subjected to IV AAV-PCSK9 injections, which were fed an atherogenic diet (D12108C, Research Diets Inc.). All experiments were approved by the Subcommittee on Animal Research Care at Massachusetts General Hospital. All efforts were made to minimize suffering. If not bred in-house, mice were acclimatized for 1-2 weeks before experiments. Mice were randomized to experimental groups; ApoE^−/−^ mice were randomized according to leukocyte blood levels and weight at the beginning of exercise. The analysis of the effect of exercise prior to cecal ligation and puncture and myocardial infarction, as well as the effect of leptin inhibition after myocardial infarction were done in a blinded fashion.

Voluntary running wheels. {#S14}
-------------------------

Mice were individually housed in cages with low-profile wireless running wheels (ENV-047, Med Associates) for 6 or 10 weeks. These open surface running wheels enabled unobstructed running by mice with mini-osmotic pump implantations. Sedentary mice were also single housed without running wheels but received a similar-size igloo for enrichment. We initially housed mice with fixed running wheels in our pilot study but did not find a significant difference to housing mice with igloos.

Sepsis induction. {#S15}
-----------------

LPS (0.5 mg/kg, from Escherichia coli 055:B5, Sigma-Aldrich) was administered intraperitoneally to mice that either had or had not previously exercised for six weeks. Cecal ligation and puncture, a model for sepsis, was carried out as previously described^[@R59]^. In brief, a small incision was made to open the peritoneal cavity under general anesthesia (1-2% isoflurane) and the cecum was exteriorized and ligated at \~30% of the cecum with a non-absorbable 7-0 suture. The distal end of the cecum was perforated using a 23G needle, and a small amount of feces was extruded through the puncture. The cecum was relocated into the peritoneal cavity, and the peritoneum was closed with sutures. Mice received buprenorphine prior to surgery and twice daily thereafter for the first three days. 1 mL of saline was administered intraperitoneally to alleviate fluid loss. Rectal temperature was measured by inserting a temperature sensor under anesthesia.

Myocardial infarction. {#S16}
----------------------

For myocardial infarction, thoracotomy was performed in the fourth left intercostal space. The left coronary artery was identified and permanently ligated with a monofilament nylon 8-0 suture. The thorax wound was then closed with sutures. Throughout the experiment mice were intubated and ventilated with 2% isoflurane supplemented with oxygen. Anti-leptin antibody (AF498) or IgG isotype control antibody (AB-108-C, both R&D Systems) were administered at a concentration of 1 mg/kg, 30 minutes after coronary artery ligation. AF498 has previously been shown to block binding of leptin to its receptor in C57BL/6J mice^[@R60]^.

Osmotic minipump implantation. {#S17}
------------------------------

Osmotic pumps (Model 2006, Alzet) were implanted subcutaneously via a small incision between the scapulae, under general anesthesia (1-2% isoflurane). Subcutaneous connective tissue was spread to create a pocket for the pump. After pump insertion, the wound was closed with sutures. Animals were given buprenorphine (0.1 mg/kg s.c.) before surgery and twice daily for the first 72 hours after implantation. Experiments were started 72 hours after implantation to allow pumping rate to reach a steady state and to avoid any effect of surgery on exercise motivation. Pump filling was performed according to manufacturer's protocol. The rate of infusion was 0.15 μl/hour, which delivers 0.3 mg/kg/day leptin for a period of 6 weeks. This dose was previously shown to not affect locomotor activity, weight gain, food intake and insulin or glucose levels^[@R61]^. Recombinant leptin (498-OB, R&D Systems) was dissolved in saline for infusion. To verify delivery, serum leptin levels and residual pump volume were routinely confirmed at the end of the experiment.

Tissue processing. {#S18}
------------------

Peripheral blood was collected by retro-orbital bleeding using heparinized capillary tubes (BD Biosciences). For flow cytometry analysis, red blood cells were lysed with 1x red blood cell lysis buffer (BioLegend). Blood was sampled and analyzed by automated complete blood count for the platelets, red blood cells, hemoglobin and hematocrit on the Element Ht5 Auto Hematology analyzer. For organ harvest, mice were perfused through the left ventricle with 20 mL of ice-cold PBS.

Bone marrow for qPCR analysis and bone marrow plasma was isolated by centrifugation. The metaphysis of one end of the tibia was removed, and the bone was spun with this 'open end' facing down at 6000 g. For bone marrow plasma, the bone marrow pellet of one tibia was resuspended in 100 uL PBS, spun down again and supernatant was kept for ELISA at −80 °C. For qPCR analysis, bone marrow was stored in RLT buffer (Qiagen) at −80 °C for further analysis. For flow cytometry analysis, bone marrow from the femurs was flushed with FACS buffer (1x PBS supplemented with 0.5 % BSA). For the LSK and stromal cell sorts, we isolated bone marrow of all long bones and pelvis. For stromal cell isolations, the bone marrow fraction was digested to isolate nestin^+^ and LepR^+^ cells, and the bone fraction was digested to isolate OCN^+^ and nestin+ cells. The bone marrow fraction was isolated by flushing the bone marrow plug with a syringe into PBS supplemented with 2% FBS. After the bone marrow plug sank to the bottom of tube, the supernatant was removed and replaced by the digestion mix: 1mg/ml collagenase IV (Sigma Aldrich, C5138), 2mg/ml Dispase (Gibco by Life technology, 17105-041) and 5 μl/ml DNAse I (Thermo scientific, 90083) in HBSS buffer (Gibco by Life Technology, 14025-092). The bone marrow plug was digested 3 × 15 minutes at 37 °C, as previously described^[@R62]^. Bones without the bone marrow plug were crushed and then cut in small pieces on a 70 μm cell strainer. Cells were washed with PBS supplemented with 2% FBS, and the bone fraction was collected and digested with Collagenase I (Stem Cell Technology, 07902), 2 mg/mL Dispase and 5μl/ml DNAse I for 45 minutes at 37°C under agitation (120 rpm).

Peritoneal cells were recovered by lavage with 10mL of ice-cold PBS supplemented with 2mM EDTA. Spleens were triturated, filtered through a 40μm filter to obtain single-cell suspensions and red blood cells were lysed with 1x red blood cell lysis buffer (BioLegend). Visceral adipose tissue (VAT) was either snap frozen for qPCR analysis or minced into small pieces and subjected to enzymatic digestion according to Orr et al.^[@R63]^ for flow cytometry. Briefly, no more than 300mg VAT was subjected to enzymatic digestion in 1mL digestion mix (1x PBS supplemented with 0.5% BSA, 10 mM CaCl~2~ and 4mg/mL collagenase type II, Worthington Biochemical Corporation) for 20 minutes at 37 °C under agitation (200 rpm). Infarct and border zone heart tissue and abdominal aortas were minced into small pieces and subjected to enzymatic digestion with 450 U/mL collagenase I (C0130), 125 U/mL collagenase XI (C7657), 60 U/mL DNase I (D5319) and 60 U/mL hyaluronidase (H3506, all Sigma-Aldrich) for 30 minutes at 37°C under agitation (750 rpm). *Gastrocnemius muscle* was minced into small pieces and subjected to enzymatic digestion with 5 mg/mL collagenase type II and 60 U/mL DNase I (Sigma, D5319) in PBS supplemented with 2 mg/ml glucose and 50 mM CaCl~2~. All digested tissues were then triturated and filtered through a 40 μm (heart, spleen, muscle) and 70 μm (VAT) nylon mesh (Falcon), washed and centrifuged to obtain single-cell suspensions.

Flow cytometry. {#S19}
---------------

All single cell suspensions were stained at 4 °C in 300μl FACS buffer (1x PBS supplemented with 0.5 % BSA). For *HSPC staining,* isolated bone marrow cells were first stained with biotin-conjugated anti-mouse antibodies directed against mouse hematopoietic lineage markers, including CD3 (100304, clone 145-2C11), CD4 (100404, clone GK1.5), CD8α (100704, clone 53-6.7), CD49b (108904, clone DX5), CD90.2 (105304, clone 30-H12), CD19 (115503, clone 6D5), B220 (103204, clone RA3-6B2), NK1.1 (108704, clone PK136), TER119 (116204, clone TER-119), CD11b (101204, clone M1/70), CD11c (117304, clone N418), Gr1 (108404, clone RB6-8C5; all 1:300, BioLegend). This was followed by a second staining with antibodies for CD16/32-BV711 (101337, clone 93), CD34-FITC (553733, clone RAM34, 1:150, BD Biosciences), CD48-AF700 (103426, clone HM48-1), CD115-BV421 (135513, clone AFS98), CD150-PerCP/Cy5.5 (115922, clone TC15-12F12.2), c-kit-PE/Cy7 (105814, clone 2B8), Sca-1-BV605 (108133, clone D7), streptavidin-APC/Cy7 (405208; all 1:300, BioLegend unless otherwise indicated). Where applicable, cells were further stained with BrdU-APC (1:50, 552598, BD Biosciences) and Ki-67-FITC (11-5698-82, clone SolA15, Thermo Fisher Scientific) during the corresponding manufacturer's staining protocols. For *aortic and cardiac leukocyte staining*, cells were first stained with PE-conjugated mouse hematopoietic lineage markers: B220 (103208, clone RA3-6B2), CD19 (115508, clone 6D5), CD3 (100206, clone 17A2), CD90.2 (140308, clone 53-2.1), and for cardiac leukocytes additionally CD49b (108908, clone DX5), CD103 (121406, clone 2E7), NK1.1 (108708, PK136) and Ter119 (116208, clone TER-119; all 1:300, BioLegend). This was followed by a second staining for CD11b-APC (101212, clone M1/70), CD45-BV711 (103147, clone 30-F11), F4/80-PECy7 (1:150, 123114, clone BM8), Ly-6C-BV605 (128035) and Ly-6G-FITC (127605; all 1:300 unless indicated otherwise, BioLegend). For blood and bone marrow *leukocyte staining,* cells were stained with B220-PE/Cy7 (103222, clone RA3-6B2) or B220-APC/Cy7 (103224, clone RA3-6B2), CD3-PE (100206, clone 17A2), CD4-PerCP/Cy5.5 (100434, clone GK1.5), CD8α-BV711 (100748, clone 53-6.7), CD19-PE/Cy7 (115520, clone 6D5) or CD19-APC/Cy7 (115530, clone 6D5), CD45-BV711 (103147, clone 30-F11) or CD45.2-AF700 (109822, clone 104), CD90.2-PE (140308, clone 53-2.1), Ly-6C-BV605 (128035, clone HK1.4), Ly-6G-FITC (127605, clone 1A8), CD11b-APC (101212, clone M1/70),and NK1.1-APC/Cy7 (108730, clone PK136, 1:300), CD115-BV421(135513, clone AFS98; all 1:600 unless indicated otherwise, BioLegend). Blood and bone marrow leukocyte staining samples were fixed with BD Cytofix (BD Biosciences) and analyzed within 24 hrs.

All cells were routinely incubated with a viability dye (FxCycle™ Violet Stain, F10347, or LIVE/DEAD^®^ Fixable Aqua Dead Cell Stain Kit for 405 nm excitation, L-34966, both Thermo Fisher Scientific, or 7-AAD, 559925, BD Biosciences) and anti-CD16/32 Fc block (553142, BD Biosciences; except HSPC staining), according to the manufacturer's protocol.

All cells were pregated on viable and single cells (FSC-A vs FSC-W, and SSC-A vs SSC-W). LSK were identified as Lin^−^ c-kit^+^ Sca-1^+^. These were further divided into long-term hematopoietic stem cells (LT-HSCs; Lin^−^ c-kit^+^ Sca-1^+^ CD150^+^ CD48^−^), short-term HSCs (ST-HSCs; Lin^−^ c-kit^+^ Sca-1^+^ CD150^−^ CD48^−^) and multipotent progenitors (MPPs; Lin^−^ c-kit^+^ Sca-1^+^ CD150^−^ CD48^+^). Common myeloid progenitors (CMP) were identified as Lin^−^ c-kit^+^ Sca-1^−^ CD16/32^mid^ CD34^+^, megakaryocyte erythroid progenitors (MEP) as Lin^−^ c-kit^+^ Sca-1^−^ CD16/32^−^ CD34^−^, granulocyte macrophage progenitors (GMP) as Lin^−^ c-kit^+^ Sca-1^−^ CD16/32^+^ CD34^+^, macrophage and dendritic cell progenitors (MDP) as Lin^−^ c-kit^+^ Sca-1^−^ CD16/32^+^ CD34^+^ CD115^+^ and B cell progenitors (B cell prog) as Lin^−^ IgM^−^ IgD^−^ B220^+^. Monocytes were identified as B220^−^ CD3^−^ CD19^−^ CD90.2^−^ NK1.1^−^ Ly-6G^−^ SSC^low^ CD11b^+^ CD115^+^, neutrophils as B220^−^ CD3^−^ CD19^−^ CD90.2^−^ NK1.1^−^ CD115^−^ SSC^low^ CD11b^+^ Ly-6G^+^, NK cells as B220^−^ CD3^−^ CD19^−^ CD90.2^−^ CD115^−^ Ly-6G^−^ SSC^low^ CD11b^+^ NK1.1^+^, eosinophils as B220^−^ CD3^−^ CD19^−^ CD90.2^−^ CD115^−^ Ly-6G^−^ NK1.1^−^ CD11b^+^ SSC^hi^, B cells as CD3^−^CD90.2^−^ CD11b^−^ B220^+^ CD19^+^ and CD3 T cells as B220^−^ CD19^−^ CD11b^−^ CD3^+^ CD90.2^+^. CD3 T cells were further subdivided into CD4^+^ and CD8^+^ T cells. Osteolineage cells (OCN^+^) cells were identified as CD45^−^ Ter119^−^ CD31^−^ GFP^+^ of OCN-GFP mice. Leptin receptor (LepR^+^) cells were identified as CD45^−^ Ter119^−^ CD31^−^ YFP^+^ or TdTomato^+^ of LeptinRcre-R26-YFP or -Tdtomato mice. Nestin^+^ cells were were identified as CD45^−^ Ter119^−^ CD31^−^ GFP^+^ of Nestin-GFP mice. Endothelial cells were identified as CD45^−^ Ter119^−^ CD31 of the bone marrow fraction of Nestin-GFP mice. For compensation, the aforementioned antibodies were conjugated to OneComp eBeads (01-1111-42, Affymetrix Inc). Unstained, YFP^+^, GFP^+^ and TdTomato^+^ control samples were used for compensation and to control the gating strategy. All data were acquired on an LSRII (BD Biosciences) and analyzed with FlowJo software. Please also see the [Life Sciences Reporting Summary](#S34){ref-type="sec"} for additional information.

Cell sorting and transplantation. {#S20}
---------------------------------

To purify bone marrow stromal cells, samples were stained with CD31-BUV737 (565097, BD Biosciences), CD45-APC/Cy7 (103116, Biolegend), Ter119-APC/Cy7 (560509, BD Biosciences), 7-AAD (BD Biosciences) and FAC-sorted with a FACSAria II cell sorter (BD Biosciences).

To purify LSK, a PE-lineage depletion was performed with MACS columns (130-042-401, Miltenyi Biotec), according to the manufacturer's protocol. Briefly, single cell suspensions were stained with a lineage cocktail of PE-conjugated antibodies: CD3 (100206, clone 17A2), CD4 (130310, clone H129.19), CD8 (100708, clone 53-6.7), CD49b (108908, clone DX5), CD90.2 (140308, clone 53-2.1), CD19 (115508, clone 6D5), B220 (103208, clone RA3-6B2), NK1.1 (108708, clone PK136), TER119 (116208, clone TER-119), CD11b (101208, clone M1/70), CD11c (117308, clone N418), Gr1 (108408, clone RB6-8C5; all 1:150, BioLegend), followed by incubation with anti-PE microbeads (130-048-801, Miltenyi Biotec). Lineage-depleted bone marrow cells were then stained with CD48-AF700 (103426, clone HM48-1), CD150-PerCP/Cy5.5 (115922, clone TC15-12F12.2), c-kit-PE/Cy7 (105814, clone 2B8), Sca-1-BV605 (108133, clone D7; all 1:150, all BioLegend) and FAC-sorted using a FACSAria II cell sorter (BD Biosciences).

All cells were pregated on single cells (as determined by FSC-A vs FSC-W, and SSC-A vs SSC-W) and viable cells (DAPI^−^ for LSK and 7AAD^−^ for stromal cells).

For bone marrow transplantations, each lethally irradiated (9.5 Gy) recipient UBC-GFP mouse received 5,000 LSK of exercising CD45.2C57BL/6J mice and 5,000 LSK of sedentary CD45.1^STEM^ mice. Each recipient CD45.1^STEM^ mouse received 5.000 LSK of post-exercise sedentary GFP mice and 5,000 LSK of either sedentary or exercising CD45.2 C57BL/6J mice. Additionally, 500,000 bone marrow cells of a UBC-GFP mouse or CD45.1^STEM^ mouse were transferred matching the recipient mouse. We used CD45.1^STEM^ mice for competitive transplantation as these are equivalent in competitive bone marrow transplantation assays to CD45.2 C57BL/6J mice^[@R50]^.

Real-time qPCR. {#S21}
---------------

Total RNA from tissues was extracted using the RNeasy Mini kit (74104, Qiagen) and from FACS-purified cells using the NucleoSpin RNA XS kit (740902.50, Takara Bio), according to the manufacturers' protocols. RNase-free DNase Set (79254, Qiagen) was used for DNase digestion during RNA purification. RNA quality was assessed by nano drop for RNA isolated from tissues and with the Agilent RNA 6000 Pico kit (5067-1513, Agilent Technologies) on the Agilent 2100 Bioanalyzer for RNA of FACS-purified cells. First-strand cDNA was synthesized using the High-Capacity RNA-to-cDNA kit (4387406 ,Applied Biosystems). TaqMan gene expression assays were used to quantify target genes, using TaqMan Fast Universal PCR Master Mix (4366072, Applied Biosystems) and primers for *Cxcl12* (Mm00445553_m1), *Vcam1* (Mm01320970_m1), *Scf* (Mm00442972_m1), *Angpt1* (Mm00456503_m1), *Il1b* (Mm00434228_m1), Pfa4 (Mm00451315_g1), *Ccl2* (Mm00441242_m1), *Il6* (Mm00446190_m1), *Il7* (Mm01295803_m1), *Tgfb1* (Mm01178820_m1), *Csf1* (Mm00432686_m1), *Csf2* (Mm01290062_m1), Csf3 (Mm00438334_m1), *Osx* (Sp7, Mm01266652_m1), *Ocn* (Bglap, Mm03413826_mH), *Runx2* (Mm00501584_m1), *Lpl* (Mm00434764_m1), *Fabp4* (Mm00445878_m1), *Leptin* (Mm00434759_m1) (all FAM probes, Applied Biosystems) and *Actb* (4352341E, VIC probe, Applied Biosystems). Samples were run on a 7500 thermal cycler (Applied Biosystems) and the relative changes were normalized to *Actb* mRNA using the 2^-DDCT^ method and normalized to sedentary controls.

Assay for transposase-accessible chromatin using sequencing (ATAC-seq). {#S22}
-----------------------------------------------------------------------

Sorted LSKs underwent ATAC-seq as previously described^[@R64],[@R65]^. Briefly, 20.000 sorted LSK cells were initially resuspended in lysis buffer and centrifuged. The nuclei pellets were then subjected to transposition reaction using the Nextera Tn5 transposase enzyme (Illumina). Tagmented DNA was purified with the MinElute PCR Purification Kit and eluted in 10 μL of elution buffer (Qiagen). Barcoded libraries were prepared and PCR amplified. Double-sided bead purification was performed using AMPure XP beads to remove primer dimers and large \>1,000 bp fragments. Libraries were sequenced 50 bp paired end on an Illumina HiSeq 2500.

Sequencing reads were first mapped to mm10 reference genome using BWA-MEM^[@R66]^ with default parameters, followed by calling peaks using HOTSPOT2^[@R67]^. As a result, at each time point we identified 8000 -- 10000 peaks, which showed high consistency between biological duplicates. The union of these peak sets (14313 peaks total) was used to calculate the ATAC-seq coverage over each peak region across all samples. Peaks with differential accessibility between conditions were identified using edgeR^[@R68]^, with the cutoffs of at least 1.5-fold difference in normalized read density and FDR\<0.01.

RNA-seq. {#S23}
--------

LSK were sorted and RNA was isolated as described above and sequencing-ready cDNA libraries were prepared using the Takara SMART-Seq v4 kit, paired with the NexteraXT Library Prep kit for Illumina, following the manufacturer's protocol. Bioanalyzer DNA High Sensitivity traces were used to confirm cDNA size distribution after the SMART-Seq step, and Agilent High Sensitivity D1000 Tapestation traces were used to check the final library size distribution. The libraries were quantified by real-time qPCR using the KAPA Library Quantification kit, and then sequenced as single-end 75 base reads on a Illumina NextSeq 500 in high-output mode.

Transcripts abundance from RNA-seq reads was quantified by Salmon^[@R69]^, and gene-level counts were obtained with tximport^[@R70]^. Subsequently, raw counts were processed with edgeR^[@R71]^ to determine differentially expressed genes. Gene set enrichment analysis (GSEA) was performed on gene lists ranked by the edgeR fold change. We used 1000 gene set permutations and the classic enrichment statistic. Gene set collections were from MSigDB (<http://software.broadinstitute.org/gsea/msigdb>). Furthermore, we used the R package ClusterProfiler^[@R72]^ to determine Gene Ontology and Reactome categories that were enriched in genes downregulated in exercising vs. sedentary groups. Raw counts from the experiment are available at Gene Expression Omnibus under the accession ID GSE124799.

Enzyme-linked immunosorbent assay. {#S24}
----------------------------------

For the leptin ELISA (MOB00, R&D Systems) measurements, blood plasma was 20x diluted and bone marrow plasma was 2x diluted. For the CXCL12 ELISA (ab100741, Abcam) measurements, bone marrow plasma was 4x diluted. For corticosterone ELISA (ab108821, Abcam) measurements, blood plasma was 50x diluted. Samples were analyzed according to the manufacturers' instructions.

Histology. {#S25}
----------

Tibiae were harvested and fixed immediately in 15 mL of formalin solution 10% (HT501128, Sigma-Aldrich) overnight at 4°C. Tibiae were then washed with distilled water, decalcified in 0.5 M EDTA (BM-711, Boston BioProducts) for 3 days and placed in 70% ethanol prior to paraffin embedding and processing. Paraffin-embedded sections were deparaffinized in xylene using two changes for 5 minutes each and rehydrated in gradually graded ethanol. For *Runx2 staining*, antigen retrieval was performed with 20 ug/mL Proteinase K (P2308, Sigma-Aldrich) for 15 minutes at 37°C and endogenous peroxidase activity was blocked with 3% H~2~O~2~/MeOH for 20 minutes at room temperature. Sections were stained with Runx2 antibody (1:200, 12556, Cell Signaling) followed by secondary goat anti-rabbit IgG antibody (1:500, BA-1000, Vector Laboratories). Further, TSA biotin detection kit (NEL700A, Perkin Elmer) was used and slides were stained with DAB Peroxidase (HRP) substrate kit (SK-4100, Vector Laboratories). For *perilipin staining,* antigen retrieval was performed using Retrievagen A (pH6.0) (550524, BD Biosciences) and sections were stained for Perilipin A (1:500, P1998, Sigma-Aldrich) followed by a biotinylated goat anti-rabbit IgG antibody (1:100, BA-1000, Vector Laboratories). Streptavidin DyLight 594 (1:600, SA-5594, Vector Laboratories) was applied to detect adipocytes and DAPI (1:3000, D21490, ThermoFisher Scientific) was used to identify nuclei.

Aortic roots were dissected and embedded in Tissue-Tek O.C.T. compound (4583, Sakura Finetek), frozen in 2-Methylbutane (78-78-4, Fisher Scientific) cooled with dry ice and sectioned into 6μm slices. To compare lesion size among the groups, Masson's Trichrome (HT15-1KT, Sigma-Aldrich) and Oil red O (O0625, Sigma-Aldrich) stainings were performed according to the manufacturers' protocol and maximum lesion areas were measured. To quantify lesion macrophage content, immunohistochemistry was performed with anti-CD68 (1:50, clone FA-11, 137002, BioLegend), Vectastain ABC kit (Vector Laboratories, Inc.) and AEC substrate (Dako). Slides were counterstained with Harris haematoxylin (Sigma-Aldrich). Images were captured on a NanoZoomer 2.0RS (Hamamatsu, Japan). Hearts were harvested and embedded in O.C. T compound. The sections were stained for CD11b (1:25, clone M1/70, 550282, BD Biosciences), collagen I (1:50, ab21286, Abcam) and alpha smooth muscle actin (1:50, αSMA, ab5694, Abcam). Biotinylated secondary antibodies were applied followed by VECTASTAIN ABC kit (PK-6100, Vector Laboratories, Inc.) and AEC substrate (K3464, Dako) for color development. Sections were counterstained with Harris hematoxylin (HHS32, Sigma-Aldrich). All slides were scanned by a digital slide scanner, NanoZoomer 2.0RS (Hamamatsu, Japan) and quantification was done using ImageJ software.

In vivo calcein labeling and calculation of mineral apposition rate. {#S26}
--------------------------------------------------------------------

Mice were intraperitoneally injected with 20 mg/kg of calcein (C0875, Sigma-Aldrich) 7 days prior and 30 mg/kg of Alizarin red S (A5533, Sigma-Aldrich) in a 2% sodium bicarbonate solution 2 days prior to harvest. Femurs were fixed for 2 hrs in formalin at 4°C and then embedded in OCT and sectioned. Images were acquired on an Olympus IV100 microscope and post-processing was performed using Image J software (NIH). Mineral apposition rate (MAR) is the distance between the midpoints of the two labels divided by the time between the midpoints of the interval.

In vitro adipocyte differentiation assay. {#S27}
-----------------------------------------

The bone marrow fraction was isolated from all long bones and pelvic bones and digested as previously described. All cells were plated in α-MEM (SH30265.01, Fisher Scientific) supplemented with 10% FBS and 1% penicillin/streptomycin (both Sigma-Aldrich). Medium was changed after 24 hours to remove non-adherent hematopoietic cells. Stromal cells were then plated in 12 well plates at a concentration of 50 x10^3^ cells per well in differentiation medium (α-MEM supplemented with 10% FBS, 1% P/S, 100 nM dexamethasone and 10 mg/ml human insulin, 1285-014, Gibco). The differentiation medium was changed twice a week, and at day 21, cells were fixed in 4% paraformaldehyde for 10 minutes, washed with 60% isopropanol, and stained with Oil Red O (O0625, Sigma-Aldrich) for 10 minutes and immediately washed with distilled water. After taking pictures, we extracted the Oil Red O with 100% isopropanol for 5 minutes with gentle rocking and the absorbance measurement was done at 492 nm. 100% isopropanol was used as background control to substract the background signal.

Microcomputed tomography (μCT). {#S28}
-------------------------------

A high-resolution desktop micro-tomographic imaging system (μCT40, Scanco Medical AG, Brüttisellen, Switzerland) was used to assess trabecular bone microarchitecture and cortical bone morphology, in the proximal metaphysis and diaphysis of the tibia, respectively. Scans were acquired using a 10 μm^3^ isotropic voxel size, 70 kVp peak x-ray tube potential, 114 μA x-ray intensity, 200 ms integration time, and were subjected to Gaussian filtration and segmentation. Image acquisition and analysis protocols adhered to guidelines for μCT assessment of rodent bone microstructure^[@R73]^. Trabecular bone microarchitecture was analyzed in a 1000 μm (100 transverse slices) long region that began 100 μm inferior to the proximal growth plate and extended distally. The endocortical region was manually contoured and then bone was segmented from soft-tissue using a threshold of 345 mgHA/cm^3^. The segmented images were analyzed with the standard Scanco trabecular bone morphology script to measure trabecular bone volume fraction (%), trabecular bone mineral density (mgHA/cm^3^), trabecular thickness (mm), trabecular number (mm^−1^), and trabecular separation (mm). Cortical bone morphology was analyzed in a 500 μm (50 transverse slices) long region that began 2 mm superior to the distal tibiofibular junction and extended distally. Cortical bone was segmented using a threshold of 700 mgHA/cm^3^ and the standard Scanco script for cortical bone morphology was used to measure total cross-sectional area (mm^2^), cortical bone area (mm^2^), cortical thickness (Ct.Th, mm), and polar moments of inertia (mm^4^).

Osmium Tetroxide μCT. {#S29}
---------------------

Marrow adipose tissue (MAT) was quantified via osmium tetroxide staining followed by μCT using previously described methods^[@R74]^. Following μCT scanning for trabecular and cortical structure, the tibiae were demineralized in 4.1% EDTA for 21 days. The demineralized tibiae were then stained at room temperature for 48 hours in a solution containing 1% osmium tetroxide and 2.5% potassium dichromate. After being washed with cold water to remove unbound osmium tetroxide, the stained tibiae were μCT imaged using the previously mentioned μCT scanner. Scans of the proximal tibia were acquired using a 10 μm^3^ isotropic voxel size, 55 kVp peak x-ray tube potential, 145 μA x-ray intensity, 300 ms integration time, and were subjected to Gaussian filtration and segmentation. The medullary cavity for each tibia was manually contoured in a region beginning 100 μm distal to the proximal growth plate and extending distally 2 mm. Osmium tetroxide staining in this region was segmented using a threshold equivalent to 800 mgHA/cm^3^ and volumetric analysis was run to measure marrow adipose tissue volume (MAT.V, mm^3^). The medullary volume (MV, mm^3^) in this region was quantified in the μCT scans of the mineralized bone as total volume minus bone volume (medullary volume = total volume -- bone volume). MAT volume was normalized by the medullary volume and is reported as the MAT volume fraction (MAT.V/MV, %).

MRI. {#S30}
----

Cardiac magnetic resonance imaging was done 21 days after coronary ligation to assess left ventricular dilatation and ejection fraction. MRI short axis views of the entire left ventricle were acquired on a Bruker 4.7 Tesla phamascan magnet (Billerica, MA) with a cine fast low angle shot sequence with intraGate technology using the following parameters: Echo Time: 2.945 ms, Repetition Time: 10.0 ms, Flip Angle: 18 deg, Oversampling: 250, Frames: 16, Matrix 200 × 200 × 1 and Voxel size 0.150 × 0.150 × 1 mm. Left ventricular wall and cavity were segmented manually at systole and diastole using Horos software (<https://horosproject.org>).

Mass Spectrometry. {#S31}
------------------

For analysis of norepinephrine (NE) and acetylcholine (ACh), bone marrow samples were homogenized in cold 10mM NH4COOH, pH 3 in 57% ACN with isotopic labeled internal standards (ACh-d4 and NE-d6). CHCl3 was added to achieve CH3CN-H2O-CHCl3 (2:1.5:1) to denature proteins, and the mixture was centrifuged for 20 min at 4°C for phase separation. The upper phase was used for UPLC-MS/MS analysis.

ACQUITY UPLC H-Class system and a Xevo TQ-S micro triple quadrupole mass spectrometer with an electrospray source, (all from Waters Inc) were used for UPLC-MS/MS analysis. Separation was performed on two types of columns. An Acquity UPLC HSS PFP (150 mm × 2.1 mm, 1.8 μm) column was used for analysis of NE with a binary gradient (Solvent A was 0.2% formic acid and solvent B was methanol) at a flow rate of 0.4 mL/min. An Acquity UPLC BEH HILIC (50 mm × 2.1 mm, 1.7 μm) column was used for analysis of acetylcholine with a binary gradient (Solvent A was 50% ACN 10mM NH4COOH pH 3 and solvent B was 95% ACN 10mM NH4COOH pH 3) at a flow rate of 0.55 mL/min. Three multiple reaction monitoring (MRM) transitions were set up for each analyte: one for quantification (ACh 146-\>87; NE 152 -\> 107), one for confirmation (ACh 146-\>43; NE 152 -\> 79), and one for labeled internal standard (ACh-d4 150-\>91; NE-d6 158 -\> 139). These MRMs were scheduled around the retention time of the analytes. Optimized cone voltage and collision energy were used for each of the individual MRMs. No less than 12 data points were collected for each peak.

Statistical analyses. {#S32}
---------------------

All statistical analyses of mouse studies were conducted with GraphPad Prism Software Version 7.0c. Data are presented as mean ± s.e.m. The sample size for each experiment is reported in the text and Figure Legends. All experiments were at least done in duplicate.

All data were first tested for normality by D'Agostino-Pearson omnibus normality test. To compare two groups of mice, we used a two-tailed Student's t-test to compare normally distributed data and a two-tailed Mann-Whitney U test for non-normal distribution. To compare three groups of mice, the Kruskal-Wallis test with Dunn's post hoc test was used for non-normal distribution. To compare two groups of mice with analysis at different time-points, a two-way analysis of variance with Sidak\'s post hoc test was used. The Mantel-Cox log rank test was performed to compare survival of sedentary versus exercising mice after cecal ligation and puncture. p\<0.05 was considered to denote significance. Statistical outliers (not more than one per experiment) were determined with the two-sided Grubbs' outlier test (Graphpad Software) and excluded.

Data and materials availability. {#S33}
--------------------------------

All data are included in this published article and its [supplementary information](#SD1){ref-type="supplementary-material"} files. Raw sequencing data are available from Gene Expression Omnibus, Accession Numbers GSE110639 and GSE124799. Raw data other than sequencing data that support the findings of this study are available from the corresponding author upon reasonable request. All materials used are available commercially. Correspondence and requests for materials should be addressed to <mnahrendorf@mgh.harvard.edu>.

Life Sciences Reporting Summary. {#S34}
--------------------------------

Further information on experimental design and reagents is available in the [Life Sciences Reporting Summary](#S34){ref-type="sec"}.

Extended Data {#S35}
=============

![Effects of 6 weeks of running.\
(**a**) Mean distance run per hour (n=24 animals). (**b**) Mean daily distance over the course of 6 weeks (n=16 animals). (**c**) Bodyweight changes in sedentary (n=12) and exercising mice (n=17, \*\*p=0.0076, two-tailed Mann-Whitney U test) compared to initial bodyweight six weeks prior. (**d**) Heart weight adjusted for tibia length (n=9 animals per group). (**e**) Food consumption during the last week of exercise (\*\*\*p=0.0002, n=9 animals per group, two-tailed Student's t-test). (**f**) Flow cytometry gating strategy for leukocytes in skeletal muscle. (**g**) Total leukocytes, neutrophils, monocytes and macrophages per mg muscle tissue by flow cytometry (n=7 animals for sedentary, n=12 for exercise). (**h**) Representative microCT images of the proximal metaphysis and mid-diaphysis tibia of exercising and sedentary mice. (**i**) Parameters of bone microstructure, including trabecular and cortical thickness, bone mineral density and polar moment of inertia by μCT (n=6 animals per group). (**j**) Representative Runx2 staining of tibial proximal metaphysis. Osteoblast surface per bone surface (Ob.S/BS, n=6 animals per group). (**k**) Bone formation rate as observed by incorporation of calcein (20 mg/kg, 7 days prior) and alizarin red (30 mg/kg, 2 days prior to sacrifice) during bone mineralization at the diaphysis of femurs. Distance of fluorescent label indicated by the arrow demarcates the mineralization front at different times of administration. '\#' denotes medullary cavity and '\#\#' trabecular bone (n=4 animals). Data are mean ± s.e.m.](nihms-1540816-f0007){#F7}

![Increased stem and progenitor cell quiescence after 6 weeks of exercise.\
Mice were given 5-bromo-2-deoxyuridine (BrdU) intraperitoneally (1 mg). BrdU incorporation in (**a**) long-term hematopoietic stem cells (LT-HSC), short-term HSC (ST-HSC), (**b**) common myeloid progenitors (CMP, \*\*\*p=0.00026), megakaryocyte erythroid progenitors (MEP, \*\*\*p=1.028×10^−5^), granulocyte macrophage progenitors (GMP, \*\*\*p=4.17×10^−4^, all n=14 animals for sedentary, n=15 for exercise), macrophage and dendritic cell progenitors (MDP, \*\*p=0.0070, n=7 animals per group) and B cell progenitors (B cell prog, \*\*p=0.0065, n=6 animals per group) were analyzed 22 hours later (two-tailed Mann-Whitney U test for CMP, MDP and B cell prog; two-tailed Student's t test for MEP and GMP). (**c**) Flow cytometry gating for hematopoietic progenitors and representative flow cytometry plots of BrdU gating. (**d**) Cell cycle analysis in LSK assessed by Ki-67/ DAPI staining. Representative flow cytometry dot plots of Ki67^+^ LSK (\*p=0.038, n=7 animals for sedentary, n=12 for exercise, 2 independent experiments, two-tailed Mann-Whitney U test). (**e**) Experimental outline for BrdU pulse-chase experiment. Mice received BrdU in drinking water for 3 weeks (baseline, n=3 animals) prior to 3 weeks of exercise. (**f**) BrdU incorporation into LT-HSC, ST-HSC, multipotent progenitors (MPP, \*\*p=0.0074), CMP (p=0.14), MEP (\*p=0.034) and GMP (p=0.07, n=9 animals for sedentary, n=4 for exercise, two-tailed Mann-Whitney U test comparing sedentary and exercise). (**g**) Representative images of granulocyte macrophage colonies from sedentary and running mice. (**h**) Bone marrow colony forming unit assay (CFU) of bone marrow mononuclear cells (BMNCs) for complete colonies (\*p=0.036, n=6 animals per group, 2 independent experiments, two-tailed Mann-Whitney U test). (**i**) Number of HSPC per femur in sedentary and exercising mice (n=15 animals per group). (**j**) Number of marrow leukocytes at Zeitgeber 13: B cells (\*\*p=0.0089), CD4 T cells, CD8 T cells (\*p=0.048), neutrophils (\*p=0.044), monocytes (\*p=0.041), eosinophils (\*p=0.019, n=5 animals for sedentary, n=6 for exercise) and NK cells (\*\*p=0.00099, n=3 per group, two-tailed Mann-Whitney U test). (**k**) Numbers of platelets (\*p=0.016, two-tailed Student's t test), red blood cells (RBC), hemoglobin (HGB) and hematocrit (HCT, n=12 animals for sedentary and n=11 for exercise, 4 independent experiments). Data are mean ± s.e.m.](nihms-1540816-f0008){#F8}

![Neutral running effects on bone marrow neurotransmitters, corticosterone and selected hematopoietic niche cells.\
(**a**) Mass spectrometry of norepinephrine and acetylcholine in the bone marrow after 6 weeks of exercise (n=5 animals per group). (**b**) Choline acetyltransferase (ChAT) expression by bone marrow CD45^+^ leukocytes (n=3 animals per group). (**c**) Experimental outline, administration of a competitive antagonist of the muscarinic acetylcholine receptors (atropine) during 3 weeks exercise. Leukocytes in circulation (n=5 animals for Sed-Saline, n=3 for Ex-Saline, n=2 for Ex-Atropine). (**d**) Plasma corticosterone at Zeitgeber time (ZG) 1 (n=11 animals for sedentary, n=8 for exercise), ZG 7 (n=8 sedentary, n=11 exercise), ZG 13 (n=6 sedentary, n=9 exercise) after exercise for 6 weeks. (**e**) Nestin^+^ stromal cells (n=6 animals for sedentary, n=8 for exercise, 3 independent experiments), (**f**) OCN^+^ osteoblasts, (n=9 animals per group, 4 independent experiments) (**g**) endothelial cells (n=8 animals for sedentary, n=10 for exercise, 6 independent experiments) and (**h**) bone marrow macrophages (n=5 animals per group, 2 independent experiments) were isolated by fluorescence-activated cell sorting. GFP stromal reporter mice either had access to exercise wheels for 6 weeks or remained sedentary. Representative dot plots are shown. Expression of *Cxcl12*, *Vcam1*, *Scf* and *Angpt1* was assessed by qPCR, ND: not detectable. (**i**) Numbers of stromal niche cells in sedentary and exercising mice (n=9 and n=8 for LepR^+^, n=6 and n=8 for Nestin^+^, n=9 and n=9 for OCN^+^, n=8 and n=10 for CD31^high^, n=5 and n=5 animals for sedentary and exercise, respectively). (**j**) Gene expression of several niche factors in total bone marrow by qPCR (n=8 animals for sedentary for *Ccl2* and *Pfa4*, n=12 for sedentary for *Tgfb*, *Csf1*, n=16 for sedentary for *Il7, Csf2*, Csf3, n=13 for exercise for *Ccl2*, *Tgfb,* n=19 for exercise for *Il7*, *Csf1, Csf2, Csf3,* 4 independent experiments). (**k**) Markers for osteolineage cells (*Osx, Ocn, Runx2*) and adipocytes (*Lpl, Fabp4*) by qPCR in total bone marrow (n=8 animals per group, 2 independent experiments). All mRNA levels were normalized to *Actb* Ct values. Data are mean ± s.e.m., where appropriate.](nihms-1540816-f0009){#F9}

![Exercise reduces visceral adipose tissue macrophages.\
(**a**) Visceral adipose tissue (VAT) per mouse adjusted for bodyweight (BW; \*\*\*p=0.00069, n=9 animals for sedentary, n=7 for exercise, 2 independent experiments, two-tailed Mann-Whitney U test). (**b**) Cytokine production by visceral adipose tissue by qPCR (\*p=0.034, \*\*p=0.0087, n=6 animals per group, 2 independent experiments, two-tailed Mann-Whitney U test). (**c**) Macrophages per mg VAT. Representative dot plots are shown (\*p=0.016, n=5 animals for sedentary, n=4 for exercise, two-tailed Mann-Whitney U test). (**d**) Experimental outline for e. Mice received BrdU in drinking water for 3 weeks (baseline, n=4 animals) prior to 3 weeks of exercise. (**e**) BrdU incorporation into VAT macrophages (\*p=0.045, n=9 animals for sedentary, n=7 for exercise, 2 independent experiments, two-tailed Mann-Whitney U test comparing sedentary and exercise). Representative dot plots are shown. (**f**) Longitudinal sections of tibias were stained by perilipin (red) and counterstained by DAPI (blue). (**g**) Quantification of adipocyte numbers and size in the proximal metaphysis of tibias (\*\*p=0.0055, n=8 animals for sedentary, n=9 for exercise, 3 independent experiments, two-tailed Mann-Whitney U test). (**h**) In vitro adipocyte differentiation assay of bone marrow stromal cells from all long bones and pelvic bones. Representative images with 100x magnification are shown (n=4 animals per group). (**i,j**) Visualization of marrow adipose tissue in tibias by osmium stain by μCT and marrow adipose tissue (MAT) per marrow volume (MV) (n=3 animals per group). (**k**) Leptin expression by qPCR in visceral adipose tissue (VAT; \*\*p=0.0022, n=6 animals per group, two-tailed Mann-Whitney U test) and bone marrow (BM; n=3 animals for sedentary, n=6 for exercise). mRNA levels were normalized to *Actb* Ct values. Data are mean ± s.e.m. (**l**) Lack of correlation between tibial adipocyte size and leptin concentration (R^2^=0.0002, P=0.96, n=17 animals, linear regression analysis).](nihms-1540816-f0010){#F10}

![Leptin supplementation and antibody neutralization.\
(**a**) Leptin levels in blood (\*p=0.19 for both Sed-Leptin vs Ex-Saline and Ex-Saline vs Ex-Leptin, one-way analysis of variance with Sidak's post hoc test) and bone marrow (\*p=0.013 Sed-Leptin vs Ex-Saline, \*p=0.042 Sed-Saline vs Ex-Saline, \*\*p=0.0038 Ex-Saline vs Ex-Leptin, n=12 animals for Sed-Saline and Ex-Saline, n=10 for Sed-Leptin, n=13 for Ex-Leptin, 5 independent experiments, Kruskal-Wallis with Dunn\'s post hoc test) as measured by ELISA. (**b**) LSK proliferation 22 hrs after intraperitoneal injection of BrdU (\*p=0.047 Sed-Saline vs Ex-Sal, p=0.05 Ex-Saline vs Ex-Leptin, \*\*\*p=0.00031 Sed-Leptin vs Ex-Sal, n=12 animals for Sed-Saline and Ex-Saline, n=10 for Sed-Leptin, n=13 for Ex-Leptin, 5 independent experiments, one-way analysis of variance with Sidak's post hoc test), LSK numbers and (**c**) expression of hematopoietic factors in bone marrow of exercising and sedentary mice implanted with osmotic minipumps as described in [Fig. 2h](#F2){ref-type="fig"} (\*p=0.016 and \*\*p=0.0026 for *Cxcl12*, \*p=0.025 Sed-Saline vs Ex-Saline and \*p=0.046 Ex-Saline vs Ex-Leptin for *Vcam1*, \*\*\*p=0.00074 Ex-Saline vs Ex-Leptin and p=0.09 Sed-Saline vs Ex-Saline for *Angpt1*, n=12 animals for Sed-Saline and Ex-Saline, n=10 for Sed-Leptin, n=13 for Ex-Leptin). (**d**) Running distance with either saline or leptin mini pumps and access to exercise wheels for 6 weeks. Mean distance run per hour (n=4 animals per group). (**e**) Injection of leptin neutralizing antibody or leptin into sedentary mice. Circulating leukocytes levels at Zeitgeber time 7 (\*p=0.010 IgG vs ⍺Lep, \*\*p=0.0072 ⍺Lep vs Leptin) and LSK proliferation 22 hrs after intraperitoneal injection (\*\*p=0.0038 IgG vs ⍺Lep, \*\*\*p=1.52×10^−5^, n=6 animals for IgG, n=7 for ⍺Lep, n=4 for Leptin, 2 independent experiments, one-way analysis of variance with Sidak\'s post hoc test). Data are mean ± s.e.m.](nihms-1540816-f0011){#F11}

![Leptin receptor expression in the bone marrow.\
(**a**) Representative flow cytometry dot plots of leptin receptor (LepR) expression in B cells, myeloid cells, T cells, (**b**) bone marrow long-term hematopoietic stem cells (LT-HSC), short-term HSC (ST-HSC), multipotent progenitors (MPP), common myeloid progenitors (CMP), megakaryocyte erythroid progenitors (MEP), granulocyte macrophage progenitors (GMP) and (**c**) stromal bone marrow cells (n=3 independent experiments with similar results). (**d**) Bone marrow colony forming unit assay (CFU) for complete colonies (n=4 donor animals). Bone marrow mononuclear cells (BMNCs) were plated with increasing concentrations of leptin. (**e**) Experimental outline for bone marrow transplantation; data shown in panel f-i. Total bone marrow was isolated from db/db donor mice and transplanted into wild type recipients. After an 8-week recovery period, mice exercised for 6 weeks or remained sedentary. (**f**) Leptin levels in serum by ELISA (\*\*p=0.0059, n=11 animals for sedentary, n=10 for exercise, 2 independent experiments, two-tailed Student's t-test). (**g**) Circulating leukocyte levels at Zeitgeber time 7 (\*\*p=0.0042, n=11 for animals sedentary, n=10 for exercise, 2 independent experiments, two-tailed Student's t-test). (**h**) BrdU incorporation into LSK 22 hrs after intraperitoneal injection (\*p=0.045, n=10 animals sedentary, n=9 for exercise, 2 independent experiments, two-tailed Student's t-test). (**i**) Gene expression by qPCR in total bone marrow of *Cxcl12* (\*p=0.042), *Vcam1* (\*p=0.03), *Scf* (\*p=0.014) and *Angpt1* (\* p=0.0168, n=11 animals for sedentary, n=10 for exercise, 2 independent experiments, two-tailed Mann-Whitney U test for *Cxcl12* and two-tailed Student's t-test for *Vcam1, Scf, Angpt1*). mRNA levels were normalized to *Actb* Ct values. (**j**) Leptin levels in blood of *Lepr*^fl/f^ and *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice measured by ELISA (n=8 animals for *Lepr*^fl/fl^ and n=11 for *Prx1*-creER^T2^:*Lepr*^fl/fl^). (**k**) Representative microCT images of the proximal metaphysis and mid-diaphysis tibia of *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice and their *Lepr*^fl/fl^ littermates. (**b**) Parameters of bone microstructure, including trabecular and cortical thickness, bone mineral density and polar moment of inertia by μCT (n=3 animals per group). Data are mean ± s.e.m.](nihms-1540816-f0012){#F12}

![Exercise effects wane after 6 sedentary weeks.\
(**a**) Experimental outline for b-c. (**b**) Blood (\*p=0.012, \*\*\*p=8.89×10^−5^) and tibial (\*\*p=0.0053, \*\*\*p=0.00079) leptin concentrations measured by ELISA (n=9 animals for sedentary and exercise, n=13 animals for post-exercise-sedentary, 3 independent experiments, Kruskal-Wallis with Dunn's post hoc test). (**c**) Gene expression of niche factors *Cxcl12* (\*p=0.015), *Vcam1* (\*p=0.038), *Scf* (\*\*p=0.0037 sedentary vs exercise, \*\*p=0.0035 exercise vs post-exercise-sedentary) and *Angpt1* (\*p=0.027) in whole bone marrow by qPCR (n=9 animals for sedentary and exercise, n=13 animals for post-exercise-sedentary, 3 independent experiments, one-way analysis of variance with Sidak's post hoc test). mRNA levels were normalized to *Actb* Ct values. (**d**) Experimental outline for e. The post-exercise-sedentary group had access to exercise wheels for 6 weeks after which the wheels were removed for the following 6 weeks. Sedentary controls had no access, while the exercise group had access to wheels during the last 6 weeks before sacrifice. (**e**) Circulating leukocyte levels at Zeitgeber time 7 (\*p=0.028 sedentary vs exercise, \*p=0.045 exercise vs post-exercise sedentary) and BrdU incorporation into LSK 22 hrs after intraperitoneal injection (\*p= 0.045 sedentary vs exercise, \*p=0.014 exercise vs post-exercise-sedentary, n=6 animals per group, Kruskal-Wallis with Dunn\'s post hoc test). (**f**) Outline of the competitive bone marrow transplantation experiments. LSK were isolated from CD45.2 donors that either exercised for 6 weeks or were sedentary. These were transplanted in a 1:1 ratio into CD45.1 recipients together with LSK isolated from UBC-GFP mice that exercised for 6 weeks and had a 3-week post-exercise-sedentary period. Blood chimerism 8 weeks after transplantation (n=4 animals per group, p=0.12 for exercise vs post-exercise-sedentary donor chimerism, Wilcoxon matched-pairs signed rank test). Data are mean ± s.e.m.](nihms-1540816-f0013){#F13}

![Background ATAC-seq signals are similar, while peaks are higher in LSK of sedentary mice.\
(**a**) Average profiles of ATAC-seq tag density among randomly shuffled regions of the same size as the actual ATAC-seq peaks. These profiles are similar among different conditions, suggesting the absence of background shift between ATAC-seq signals. (**b**) Tracks of normalized ATAC-seq tag density for the loci of additional genes in the top ten significant genes in the cell cycle category as determined by DAVID in [Fig. 3n](#F3){ref-type="fig"}. (**c**) Scatter plot of normalized tag density at ATAC-seq peaks shows comparison between LSK from sedentary versus post-exercise-sedentary cohorts. Peaks with significantly lower and higher tag density in post-running mice are highlighted in orange and black, respectively (FDR\<0.01). The top ten significant genes in the cell cycle pathway determined by DAVID (refer to d) and *Mki67* are indicated; see [Supplementary Table 1](#SD1){ref-type="supplementary-material"} for all genes. (**d**) Functional categories enriched among genes with differential chromatin accessibility in LSK from sedentary versus post-exercise-sedentary mice as determined by DAVID. (**e**) Tracks of normalized ATAC-seq tag density for the loci of the top ten significant genes in the cell cycle category as determined by DAVID in d.](nihms-1540816-f0014){#F14}

![Leptin in acute MI.\
(**a**) Experimental outline for b-e. (**b**) Leptin blood levels on day 6 after MI (n=5 animals for Sed-Saline and Ex-Saline, n=6 for Ex-Leptin, 3 independent experiments). (**c**) Infarct CD45^+^ leukocyte levels on day 6 after MI (\*p=0.025, n=5 animals for Sed-Saline and Ex-Saline, n=6 for Ex-Leptin, 3 independent experiments, Kruskal-Wallis with Dunn's post hoc test). (**d**) Flow cytometry gating and quantification of neutrophils (\*p=0.039 Sed-Saline vs Ex-Leptin, \*p=0.021 Ex-Saline vs Ex-Leptin), monocytes (\*p=0.018 Sed-Saline vs Ex-Leptin, \*p=0.015 Ex-Saline vs Ex-Leptin), macrophages and lymphocytes in the infarct in respective cohorts (n=5 animals for Sed-Saline and Ex-Saline, n=6 for Ex-Leptin, 3 independent experiments, Kruskal-Wallis with Dunn's post hoc test). (**e**) Cardiac magnetic resonance imaging on day 21 after MI. Ejection fraction (EF), enddiastolic volume (EDV), endsystolic volume (ESV) and left ventricular (LV) mass were determined (n=7 animals for Sed-Saline, n=5 for Ex-Saline, n=8 for Ex-Leptin, 3 independent experiments). (**f**) Experimental outline for panels g-j. (**g**) Circulating leukocytes at Zeitgeber 7 (\*\*p=0.0017, n=8 animals for IgG and n=10 for ⍺Lep, 3 independent experiments, two-tailed Student's t test). (**h**) BrdU incorporation into granulocyte macrophage progenitors (GMP) 3 days after MI (p=0.05, n=8 animals for IgG and n=10 for ⍺Lep, 3 independent experiments, two-tailed Student's t-test). (**i**) Bone marrow colony forming unit assay (CFU) of bone marrow mononuclear cells (BMNCs) for complete colonies (\*\*\*p=0.00041, n=7 animals for IgG and n=10 for ⍺Lep, 3 independent experiments, two-tailed Mann-Whitney U test). (**j**) Neutrophils and monocytes per mg infarct tissue (\*p=0.03, n=5 animals for IgG, n=6 for ⍺Lep, two-tailed Mann-Whitney U test). (**k**) Experimental outline for l. (**l**) Representative immunohistochemical stainings and quantification of myeloid cells (CD11b), collagen deposition (Collagen I), and myofibroblasts (alpha smooth muscle actin) in the infarct border zone (\*p=0.026 for CD11b and Collagen I, n=6 animals per group, two-tailed Mann-Whitney U test). Data are mean ± s.e.m.](nihms-1540816-f0015){#F15}

![Stromal leptin receptor deletion attenuates atherosclerosis, inflammation and hematopoiesis.\
(**a**) Experimental outline for b-h. *Lepr*^fl/fl^ mice and *Prx1*-creER^T2^:*Lepr*^fl/fl^ littermates were injected with tamoxifen and received a single IV injection of AAV-PCSK9 followed by a high fat diet for 12 weeks. (**b**) Representative cross sections of aortic roots stained with Oil red O and assessment of lesion size (\*p=0.042, n=8 animals per group, two-tailed Student's t-test). (**c**) Flow cytometry enumeration of myeloid cells in aortas of *Lepr*^fl/fl^ and *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice (\*p=0.023, n=8 animals per group, two-tailed Student's t-test). (**d**) CD68 histological staining of aortic root lesions. Percentage of positive staining per plaque (\*p=0.029, n=6 animals for *Lepr*^fl/fl^, n=8 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, two-tailed Mann-Whitney U test). (**e**) Representative flow plots and statistical analysis of long-term hematopoietic stem cells (LT-HSC) in femur bone marrow (\*p=0.046, n=9 animals per group, two-tailed Student's t-test). (**f**) Bone marrow colony forming unit assay for complete colonies (CFU-C) of bone marrow mononuclear cells (BMNCs) (\*p=0.036, n=9 animals per group, two-tailed Student's t-test). (**g**) BrdU incorporation assay 22 hours after intraperitoneal injection for LT-HSC and granulocyte-macrophage progenitors (GMP) proliferation (\*p=0.027 for LT-HSC, \*p=0.017 for GMP, n=9 animals per group, two-tailed Student's t-test). (**h**) Circulating myeloid cells at Zeitgeber time 7 (\*p=0.014 for neutrophils, \*p=0.046 for monocytes, n=10 animals for *Lepr*^fl/fl^, n=9 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, two-tailed Student's t-test). Data are mean ± s.e.m. (**i**) Athero-express cohort. The flow chart illustrates inclusion criteria for patients and separation into sedentary lifestyle and exercise groups.](nihms-1540816-f0016){#F16}
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![Exercise increases HSPC quiescence.\
(**a**) Experimental outline. Hematopoietic parameters were measured in C67BL/6 mice that had access to exercise wheels for 6 weeks (exercise) or not (sedentary). (**b**, **c**) Proliferation of hematopoietic stem and progenitor cells (LSK; Lin^−^ Sca-1^+^ c-kit^+^) and multipotent progenitor cells (MPP), as analyzed by BrdU incorporation using flow cytometry. Representative dot plots for LSK (**b**) and statistical analysis (**c**) are shown (\*\*p=0.0023, \*\*\*p=4.25×10^−8^, n=14 sedentary, n=15 exercising animals, 4 independent experiments, two-tailed Student's t-test). (**d**) Colony forming unit assay (CFU) of bone marrow mononuclear cells (BMNCs) for granulocytes and macrophages (GM), pre-B cells (preB) and burst-forming unit-erythroid (BFU) (\*\*\*p=0.00012 for GM, \*\*\*p=4.22×10^−5^ for preB, p=0.052 for BFU, n=9 animals per group, two-tailed Student's t-test). (**e**) Circulating stem cells measured by CFU assay for complete colonies (\*p=0.018, n=9 animals per group, 2 independent experiments, two-tailed Student's t-test). (**f-h**) Circadian rhythm of leukocyte numbers in the blood (**f**) (\*p=0.029 for Zeitgeber time (ZG) 5, \*p=0.038 for ZG 9, \*\*p=0.0025 for ZG 7, n=12 animals for ZG 1, 5, 7, 9, 21, n=8 for ZG 13, 17 for sedentary, n=17 for ZG 1, n=18 for ZG 5, 7, 9, 21, n=12 for ZG 13, 17 for exercise, 3 independent experiments, two-way analysis of variance with Sidak\'s post hoc test), bone marrow (**g**) (\*\*\*p=2.14×10^−6^, n=8 and n=11 animals for ZG 1, n=8 and n=12 for ZG 7 for sedentary and exercise, respectively, n=9 per group for ZG 13, n=3 per group for ZG 21; 8 independent experiments, two-way analysis of variance with Sidak\'s post hoc test) and spleen (**h**) (\*p=0.012, n=4 and n=5 animals for ZG 1, n=7 and n=12 for ZG 7 for sedentary and exercise, respectively, n=6 per group for ZG 13, n=3 per group for ZG 21, 4 independent experiments, two-way analysis of variance with Sidak\'s post hoc test). (**i**) Flow cytometry gating for blood leukocytes at ZG 7. (**j**) Leukocyte subsets in circulation at ZG 7 (\*p=0.044 for neutrophils,\*p=0.019 for monocytes, \*\*p=0.0025 for CD8 T cells, \*\*p=0.0057 for eosinophils, \*\*\*p=0.00022 for B cells, \*\*\*p=4.96×10^−6^ for CD4 T cells, n=14 and n=18 animals for B cells, T cells, monocytes, n=14 and n=17 for neutrophils, n=10 and n=12 for eosinophils and NK cells for sedentary and exercise, respectively, 4 independent experiments, two-tailed Student's t-test comparing sedentary and exercise for each cell subset). Data are mean ± s.e.m. We acknowledge servier medical art ([www.smart.servier.com](http://www.smart.servier.com)) for providing images of mice and cartoon components.](nihms-1540816-f0001){#F1}

![Exercise dampens hematopoiesis by reducing adipose tissue leptin production.\
(**a**) Experimental outline for panels **b**-**g**. C57BL/6 or LepR-YFP stromal reporter mice had access to exercise wheels for 6 weeks or remained sedentary. (**b**) Gene expression of maintenance factors in total bone marrow of C57BL/6 mice, as measured by qPCR (\*p=0.017 for *Cxcl12*, \*p=0.047 for *Vcam1*, \*p=0.022 for *Scf*, \*p=0.01 for *Angpt1*, n=12 and n=13 animals for *Cxcl12,* n=12 and n=14 for *Vcam1*, *Scf*, *Angpt1*, for sedentary and exercise, respectively, 3 independent experiments, two-tailed Student's t-test). (**c**) Protein levels by ELISA in tibia marrow plasma (\*p=0.021, n=7 animals for sedentary and n=8 for exercise, 2 independent experiments, two-tailed Mann-Whitney U test). (**d**) Left, representative plots for flow sorting LepR-YFP^+^ stromal cells. Right, expression of maintenance factors as assessed by qPCR (\*\*\*p=0.009 for *Cxcl12*, \*p=0.018 for *Vcam1*, \*\*\*p=0.0005 for *Scf*, \*\*p=0.0071 for *Angpt1*, n=8 animals per group for *Cxcl12*, n=8 and n=9 for *Vcam1*, *Scf*, *Angpt1* for sedentary and exercise, respectively, 6 independent experiments, two-tailed Mann-Whitney U test). (**e-g**) Leptin expression, as measured by qPCR in visceral adipose tissue (\*\*p=0.0022, n=6 animals per group, 2 independent experiments, Mann-Whitney U test) (**e**) and blood (\*\*\*p=0.0007, n=15 animals per group, 3 independent experiments, two-tailed Mann-Whitney U test) (**f**) and bone marrow (\*\*\*p=0.0003, n=19 animals for sedentary and n=18 for exercise, two-tailed Mann-Whitney U test) by ELISA (**g**). (**h**) Left, experimental outline; osmotic minipumps producing saline or leptin were implanted subcutaneously in C57BL/6J mice, which then were allowed to exercise or not starting 3 days after implantation. Right, levels of circulating leukocytes at Zeitgeber time 7 (\*\*p=0.0015 for Ex-Saline vs Ex-Leptin, \*\*\*p=0.0009 for Sed-Saline vs Ex-Saline, \*\*\*p=1.77×10^−7^ for Sed-Leptin vs Ex-Saline, n=13 animals for Sed-Saline and Ex-Leptin, n=9 for Sed-Leptin, and n=12 for Ex-Saline, 5 independent experiments, one-way analysis of variance with Sidak\'s post hoc test). (**i**) Experimental outline for panels **j**-**l**. *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice or their *Lepr*^fl/fl^ littermates were injected 3 times with tamoxifen every other day and were sacrificed 2 weeks after the last injection. (**j**) Gene expression in total bone marrow, as measured by qPCR (\*p=0.02 for *Cxcl12*, \*\*p=0.0094 for *Vcam1*, \*\*p=0.0064 for *Scf*, \*\*p=0.0099 for *Angpt1*, n=8 animals for *Lepr*^fl/fl^ and n=9 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 3 independent experiments, two-tailed Student's t-test) (**k**) BrdU incorporation into LSK, as measured by FACS, 22 hrs after intraperitoneal injection (\*p=0.043, n=6 animals for *Lepr*^fl/fl^ and n=8 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 2 independent experiments, two-tailed Mann-Whitney U test). (**l**) Circulating leukocyte levels at Zeitgeber time 7 (\*\*\*p=1.7×10^−5^, n=8 animals for *Lepr*^fl/fl^ n=9 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 3 independent experiments, two-tailed Student's t-test). All mRNA levels were normalized to *Actb* Ct values. Data are mean ± s.e.m. We acknowledge servier medical art ([www.smart.servier.com](http://www.smart.servier.com)) for providing images of mice and cartoon components.](nihms-1540816-f0002){#F2}

![Voluntary running reduces LSK chromatin accessibility.\
(**a**) Experimental outline for **b**. Sedentary control C57BL/6J mice had no access to exercise wheels (top); the exercise group had access to wheels during the last 6 weeks before sacrifice (middle), and the post-exercise-sedentary group had access to wheels for 6 weeks after which the wheels were removed for the following 3 weeks (bottom). (**b**) Circulating leukocyte levels (\*p=0.033, \*\*p=0.0025, n=9 animals for sedentary and exercise, n=6 for post-exercise-sedentary, 3 independent experiments, Kruskal-Wallis test with Dunn\'s post hoc test) at Zeitgeber time 7 and BrdU incorporation in LSK, as measured 22 hours after intraperitoneal injection (\*\*p=0.0043, n=8 for sedentary and n=7 for exercise and post-exercise-sedentary, 2 independent experiments, Kruskal-Wallis test with Dunn\'s post hoc test). (**c**) Experimental outline of competitive bone marrow transplantation experiments in **d**-**g**. LSK were isolated from donors that had either exercised for 6 weeks (CD45.2) or were sedentary (CD45.1^STEM^) and were then transplanted in a 1:1 ratio into irradiated UBC-GFP recipients. (**d**) Left, flow cytometry plots of circulating leukocytes after transplantation. The left panel depicts a control that had received LSK from a sedentary CD45.2 mouse and a sedentary CD45.1^STEM^ mouse, whereas the right panel depicts the experimental group as diagrammed in **c**. (**e**) Blood chimerism 4 weeks after transplantation (\*p=0.016, n=7 animals per group, Wilcoxon matched-pairs signed rank test). (**f**) Dot plot and quantification of bone marrow LSK chimerism (n=8 animals per group). (**g**) BrdU incorporation in LSK 22 hours after intraperitoneal injection (\*\*\*p=0.0006, n=7 animals per group, 2 independent experiments, two-tailed Mann-Whitney U test) and LT-HSC chimerism (n=5 animals per group). Data are mean ± s.e.m. (**h**) Experimental outline for **i**-**n**. LSK were isolated from the experimental groups in **a** and subjected to ATAC-seq analysis. (**i**) Genomic distribution of ATAC-seq peaks (numbers in pie chart) in LSK among genes, promoters, enhancers and other intergenic regions. (**j**) Profiles of average ATAC-seq tag density over all transcriptional start site (TSS)-proximal regions (TSS ± 3 kb) in LSK. Each curve refers to individual mouse, see **h** for color coding. (**k**) Scatter plot of normalized tag density at ATAC-seq peaks comparing LSK from sedentary versus exercise cohorts. Peaks with significantly lower and higher tag density in running mice are highlighted in orange and black, respectively (FDR\<0.01). The top ten significant genes in the cell cycle pathway, as determined by DAVID (refer to **n**), and *Mki67* are indicated; see [Supplementary Table 1](#SD1){ref-type="supplementary-material"} for all genes. (**l**) Patterns of chromatin accessibility among 3605 TSS-proximal peaks (within TSS ± 3Kbp) with differential ATAC-seq signal between conditions (FDR\<0.01). Heatmap color indicates the ATAC-seq tag density relative to the average across all samples for the given peak. (**m**) Tracks of normalized ATAC-seq tag density for the Mki67, Kif23, Haus3, Taf1 and Crocc loci. (**n**) Functional pathway categories of differential chromatin accessibility in sedentary versus exercising mice as determined by DAVID. (**o**) Enrichment analysis of the gene set "Reactome Cell Cycle" in RNA-seq of LSK from mice in exercise and post-exercise-sedentary versus sedentary groups. Genes were ranked by log2-fold change. (**p,q**) Gene ontology biological process categories (**p**) and Reactome gene sets (**q**) enriched in genes that are at least two-fold downregulated in exercising mice versus sedentary mice. Gene ratio, fraction of tested genes belonging to each gene set. P-values are from the hypergeometric distribution. (**r**) Enrichment analysis of gene sets related to oxidative phosphorylation in LSKs from exercising vs. sedentary mice. Genes were ranked by log2-fold change. Experimental groups in **o**-**r** are as diagrammed in **a** (Ex, exercise; Post-Ex-Sed, sedentary after exercise; All Ex, combination of Ex and Post-Ex-Sed). All FDR values were calculated with the Benjamini-Hochberg Procedure. We acknowledge servier medical art ([www.smart.servier.com](http://www.smart.servier.com)) for providing images of mice and cartoon components.](nihms-1540816-f0003){#F3}

![Exercise augments emergency hematopoiesis and improves survival in sepsis.\
(**a**) Experimental outline for panels **b**-**e**. C57BL/6J mice received intraperitoneal injections of LPS after 6 weeks of exercise or no exercise. Analysis was performed 24hrs after LPS injection. (**b**) Bone marrow colony forming unit assay (CFU) of bone marrow mononuclear cells (BMNCs) (\*p=0.048, n=7 animals per group, 2 independent experiments, two-tailed Mann-Whitney U test). (**c**) Bone marrow common myeloid progenitors (CMP), granulocyte macrophage progenitors (GMP) and macrophage dendritic cell progenitors (MDP) 24 hours after LPS injection (\*p=0.018, \*\*\*p=0.0004 for CMP, \*\*\*p=0.0008 for GMP, n=10 animals for sedentary, n=9 for exercise, 3 independent experiments, two-tailed Mann-Whitney U test). (**d**) Numbers of neutrophils (\*p=0.01), monocytes (\*\*p=0.0028), B (\*p=0.038) and T cells (\*p=0.04) in the circulation (n=10 and n=9 animals for neutrophils and monocytes, n=10 and n=8 for B and T cells for sedentary and exercise, respectively, 3 independent experiments, two-tailed Mann-Whitney U test) and (**e**) peritoneal cavity after LPS (\*p=0.038 for monocytes, \*p=0.011 for B cells, \*p=0.018 for T cells, n=7 and n=6 animals for neutrophils for sedentary and exercise, respectively, n=7 per group for monocytes, B and T cells, 2 independent experiments, two-tailed Mann-Whitney U test). (**f**) Experimental outline for panels **g**-**h**. Cecal ligation and puncture (CLP) was induced after 6 weeks of exercise or in sedentary controls. (**g**) Body core temperature was measured before CLP surgery (baseline) and 48 hours after CLP (\*\*p=0.0043, n=6 animals for baseline and n=5 for each CLP group, 2 independent experiments, two-tailed Mann-Whitney U test comparing sedentary and exercise post-CLP). Data are mean ± s.e.m. (**h**) Survival after CLP (\*p=0.012, n=11 sedentary and n=10 exercise mice post-CLP, 3 independent experiments, Mantel-Cox log-rank test). We acknowledge servier medical art ([www.smart.servier.com](http://www.smart.servier.com)) for providing images of mice and cartoon components.](nihms-1540816-f0004){#F4}

![Disrupting leptin signaling reduces hematopoiesis and inflammation in acute myocardial infarction.\
(**a**) Left, serum leptin levels (\*\*p=0.0089, n=5 animals per group, Kruskal-Wallis with Dunn\'s post hoc test) and right, bone marrow leptin levels (\*p=0.017 for control vs MI day 1, \*p=0.015 for MI day 1 vs day 3, n=4 animals for control, n=7 for MI day 1, n=5 for MI day 3, Kruskal-Wallis with Dunn\'s post hoc test) at days 1 or 3 after MI in C57BL/6J mice or naive controls, as measured by ELISA. (**b**) Experimental outline for panels **c**-**g**. *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice or their *Lepr*^fl/fl^ littermates received a myocardial infarct 4 weeks after having been injected 3 times with tamoxifen every other day. Mice were sacrificed 3 days after MI. (**c**) Gene expression in total bone marrow, as measured by PCR (\*p=0.035 for *Cxcl12*, \*p=0.014 for *Vcam1*, \*\*p=0.0023 for *Scf*, \*\*p=0.0087 for *Angpt1*, n=6 animals for *Lepr*^fl/fl^ and n=7 for *Prx1*-creER^T2^:*Lepr*^fl/fl^ for *Cxcl12*, *Vcam1*, *Scf*, n=6 per group for *Angpt1*, 2 independent experiments, two-tailed Mann-Whitney U test). mRNA levels were normalized to *Actb* Ct values. (**d**) BrdU incorporation into LSK 22 hrs after intraperitoneal injection, as measured by FACS (\*p=0.022, n=6 animals for *Lepr*^fl/fl^ and n=7 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 2 independent experiments, two-tailed Mann-Whitney U test). (**e**) Left, bone marrow colony forming unit assay (CFU) of bone marrow mononuclear cells (BMNCs) for complete colonies (CFU-C) (\*\*p=0.0012, n=6 animals for *Lepr*^fl/fl^ and n=7 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 2 independent experiments, two-tailed Mann-Whitney U test) Right, representative image of assay. (**f**) Circulating leukocyte levels (\*p=0.022, n=6 animals for *Lepr*^fl/fl^ and n=7 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 2 independent experiments, two-tailed Mann-Whitney U test). (**g**) Neutrophil (\*\*p=0.0082), monocyte (\*\*p=0.0012), macrophage (\*\*p=0.0012) and lymphocyte (\*\*p=0.0047) numbers in the infarct (n=6 animals for *Lepr*^fl/fl^ and n=7 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 2 independent experiments, two-tailed Mann-Whitney U test). (**h**) Experimental outline for panels **c**-**g**. Mice received 3 tamoxifen injections every other day and an MI 2 weeks later. Cardiac MRI was done 3 weeks post MI. (**i,j**) Cardiac MRI in *Prx1*-creER^T2^:*Lepr*^fl/fl^ mice and their *Lepr*^fl/fl^ littermates, representative short-axis images (**i**) and statistical analysis (**j**) (\*\*p=0.0097 for EDV, \*\*p=0.0046 for ESV, \*p=0.043 for EF, n=7 animals for *Lepr*^fl/fl^ and n=10 for *Prx1*-creER^T2^:*Lepr*^fl/fl^, 3 independent experiments, two-tailed Mann-Whitney U test). We acknowledge servier medical art ([www.smart.servier.com](http://www.smart.servier.com)) for providing images of mice and cartoon components.](nihms-1540816-f0005){#F5}

![Sedentary lifestyle accelerates leukocyte supply in mice and humans with atherosclerosis.\
(**a**) Experimental outline for **b**-**j**. ApoE^−/−^ mice consumed a Western-type diet for a total of 20 weeks. After 10 weeks, half of them were given access to a running wheel for 10 weeks. (**b**) Leptin concentration in blood (\*\*p=0.0011) and tibia (\*\*\*p= 4.06×10^−5^, n=18 animals for sedentary and n=10 for exercise, 4 independent experiments, two-tailed Mann-Whitney U test). (**c-f**) Circulating leukocytes as measured by flow cytometry, during the last ten weeks of diet (**c**) (\*p=0.017, \*\*\*p=1.9×10^−7^ for 8 weeks, \*\*\*p= 6×10^−8^ for 10 weeks, n=19 and n=13 animals for week 0, n=4 and n=5 for week 2, n=20 and n=14 for week 8, n=21 and n=14 for week 10 for sedentary and exercise, respectively, n=5 per group for week 4, n=7 per group for week 6, two-way analysis of variance with Sidak's post hoc test). (**d**) Flow cytometry gating strategy for leukocytes. (**e**) Blood myeloid cells (\*\*p=0.0011, n=21 animals for sedentary and n=13 for exercise) and lymphocytes (\*p=0.034, n=20 for sedentary and n=13 for exercise, 4 independent experiments, two-tailed Student's t-test) in circulation. (**f**) Neutrophils (\*\*p=0.069, n=21 animals for sedentary and n=13 animals for exercise), monocytes (\*\*\*p=0.00058, n=20 and n=14), B (\*p=0.042, n=20 and n=13) and T cells in circulation (n=21 and n=14 for sedentary and exercise, respectively, 4 independent experiments, two-tailed Mann-Whitney U test). (**g**) Flow cytometry gating in aorta and (**h**) enumeration of neutrophils (\*\*p=0.0036), monocytes (\*p=0.046), macrophages (\*\*\*p=1.88×10^−5^) and lymphocytes (\*p=0.015, n=16 animals for sedentary and n=9 for exercise, two-tailed Student's T test). (**i**) Masson's Trichrome histology images of aortic root for plaque size analysis (**j**) (\*\*p=0.0043, n=18 animals for sedentary and n=12 for exercise, two-tailed Student's t-test). Data are mean ± s.e.m. (**k**) Left, cohorts and numbers among 4,892 participants in the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) according to self-reported exercise levels. Right, median values and interquartile ranges for leptin and the total leukocyte count according to exercise level. Effects were statistically significant across exercise groups for both leptin and leukocyte count in both univariate and multivariate models. (**l**) Left, cohorts and numbers of patient from the Athero-Express study according to exercise level. Right, median values and interquartile ranges for leptin and the total leucocyte count (also see [Extended Data Fig. 10i](#F16){ref-type="fig"} and [Supplementary Tables 3](#SD1){ref-type="supplementary-material"}--[5](#SD1){ref-type="supplementary-material"}) (one-way analysis of variance and multivariate linear regression models with correction for age, sex, BMI, diabetes, hypercholesterolemia and statin use). (**m**) Summary cartoon, see text for details. We acknowledge servier medical art ([www.smart.servier.com](http://www.smart.servier.com)) for providing images of mice and cartoon components.](nihms-1540816-f0006){#F6}
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